Mediating effects of fatigue and health promotion behaviors on cognition and quality of life among patients with gastrointestinal cancer undergoing chemotherapy: a cross-sectional study | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Mediating effects of fatigue and health promotion behaviors on cognition and quality of life among patients with gastrointestinal cancer undergoing chemotherapy: a cross-sectional study Boram Lee, Sunki Kim, Hye-Ja Park This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7454615/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Purpose Cognitive disability, a common symptom among patients with gastrointestinal cancer undergoing chemotherapy, is frequently accompanied by fatigue and poor health promotion behaviors. These symptoms impair quality of life; however, their interrelationships remain unclear. This study aimed to determine whether fatigue and health promotion behaviors mediate the relationship between cognition and quality of life in patients with gastrointestinal cancer undergoing chemotherapy. Methods In this cross-sectional study, 127 patients were recruited from a university hospital in South Korea. A quantitative mediation analysis was conducted. The participants completed validated self-report measures assessing cognition, fatigue, behaviors, and quality of life. Data were analyzed using Hayes’ Process Macro with 50,000 bootstrap replicates. Results Our findings revealed that cognition influenced fatigue (B = 0.47, p = 0.003), health promotion behaviors (B = − .35, p < 0.001), and quality of life (B = -0.51, p < 0.001), and fatigue and health-promoting behaviors mediated the relationship between cognition and quality of life (B = − .26, (95% CI, -0.345, -0.171), p < 0.001; B = 0.61, (95%CI, 0.453, 0.779), p < 0.001). Conclusion Cognition influences fatigue and health promotion behaviors, thereby directly impacting quality of life. Our findings support the need for integrated symptom management approaches in patient care. Interventions targeting fatigue and health promotion behaviors may be effective in reducing cognitive disability and improving the quality of life in patients with gastrointestinal cancer undergoing chemotherapy. cognition fatigue health promotion quality of life Figures Figure 1 1. Introduction The incidence of cancer-related mortality is increasing worldwide. For example, in Korea, gastrointestinal (GI) cancers, such as colorectal and gastric, remain highly prevalent, with colorectal, gastric, pancreatic, gallbladder, and bile duct cancers being the most common malignancies [ 1 ]. The primary treatment options for GI cancers, either alone or in combination, include surgery, chemotherapy, radiotherapy, and targeted therapy. Recent advances in therapeutic technology have improved patient outcomes. Indeed, in Korea, for example, the 5-year relative survival rate of patients with cancer is increasing steadily to 72.9% [ 2 , 3 ]. Among these modalities, chemotherapy involves the systemic administration of cytotoxic drugs to destroy or inhibit the growth of cancer cells. Along with rapidly dividing cancer cells, first-generation chemotherapeutic agents also target and damage normal cells, leading to severe adverse effects such as neutropenia, alopecia, stomatitis, diarrhea, nausea, and vomiting. Meanwhile, despite having fewer side effects, second- and third-generation agents are only limited to specific malignancies [ 1 ]. Approximately 75% of patients with GI cancer undergoing chemotherapy experience systemic side effects, including bone marrow suppression, GI complications, alopecia, fatigue, immunosuppression, and neurotoxic manifestations—such as cognitive impairment, peripheral neuropathy, depression, and anxiety, which reduce their quality of life (QoL) [ 4 , 5 ]. In particular, chemotherapy-related cognitive impairment negatively affects patients’ daily functioning and engagement in health-promoting behaviors (HPBs), making it a critical determinant of QoL [ 6 , 7 ]. Cancer-related cognitive impairment has been reported in up to 45% of cancer survivors [ 8 ], with chemotherapy-induced impairment occurring in approximately one-third of all patients [ 7 ]. Although the underlying mechanisms are not fully understood, chemotherapy crosses the blood–brain barrier, damages neuronal DNA, and induces neurotoxicity [ 9 ]. Cognitive decline is most prominent within the first year post-chemotherapy, with some patients experiencing recovery over time, while others face ongoing deficits [ 7 , 10 ]. Recent evidence suggests that cancer-related cognitive impairment arises not only from the direct neurotoxic effects of chemotherapy but also the interplay of social determinants of health, patient-specific factors, co-occurring symptoms, treatment-related factors, and other biological mechanisms [ 11 ]. Therefore, cancer-related cognitive impairment may be influenced by psychological distress, fatigue, hormonal alterations, and pharmacological factors [ 7 , 11 ]. This necessitates assessments and preventive strategies for cancer-related cognitive impairment [ 4 , 7 , 10 , 11 ]. Cancer-related fatigue, another prevalent symptom, affects approximately 49% of survivors undergoing chemotherapy [ 12 ]. The National Comprehensive Cancer Network defines cancer-related fatigue as a distressing, persistent, and subjective sense of physical, emotional, or cognitive tiredness associated with cancer or its treatment that is disproportionate to recent activities and interferes with daily functioning [ 13 ]. Cancer-related fatigue may persist beyond the active treatment phase, potentially lasting for two years post-therapy, and is associated with impaired QoL [ 14 ]. Fatigue has also been linked to depression, anxiety [ 4 ], reduced HPBs [ 15 ], and diminished QoL [ 4 , 16 , 17 ]. Conversely, alleviating fatigue contributes to improved QoL [ 18 ]. Physical exercise, physiotherapy, cognitive-behavioral therapy, and sleep therapy, among other non-pharmacological interventions, have been shown to reduce cancer-related fatigue [ 17 , 18 ]. However, cancer-related fatigue is often underassessed and undertreated in clinical practice due to its subjective nature, highlighting the need for routine evaluation and management [ 17 ]. HPBs refer to the proactive, self-directed health actions through which individuals take responsibility for their well-being [ 19 ]. Among patients with cancer, HPBs are associated with recurrence prevention, physical and mental health maintenance, and overall well-being [ 20 ]. In particular, patients with GI cancer require nutritional attention as part of their HPBs, along with exercise, stress management, interpersonal relationships, and adherence to healthy lifestyle practices [ 21 ]. HPBs not only reduces the risk of recurrence but also improves physical and psychological health, thereby enhancing the overall QoL [ 16 , 22 , 23 ]. Cognitive function, fatigue, and HPBs are major predictors of survival and QoL in patients with GI cancer across the continuum of care from pre-chemotherapy to active treatment and long-term survivorship [ 23 , 24 ]. Specifically, cognitive decline is closely associated with fatigue [ 6 ], leading to an impaired QoL [ 4 , 25 ]. Fatigue and HPBs are also strongly associated with QoL; exercise and other HPBs interventions have been shown to alleviate fatigue and enhance QoL [ 12 ]. However, there is limited evidence regarding the mediating role of fatigue and HPBs in the relationship between cognitive function and QoL. Moreover, in clinical settings, patient-reported domains are often perceived as individual concerns, resulting in limited active interventions by healthcare providers. Therefore, this study aimed to investigate the mediating effects of fatigue and HPBs on the relationship between cognitive function and QoL among patients with GI cancer undergoing chemotherapy. 2. Methods 2.1. Study Design and Participants This cross-sectional descriptive study employed a quantitative mediation analysis to examine the mediating roles of fatigue and HPBs between cognition and QoL in patients with GI cancer receiving chemotherapy. Data were collected from outpatient and oncology units at a university-affiliated cancer center in Gyeonggi-do, Republic of Korea. Sample size was estimated using G*Power 3.1.9.7 for linear multiple regression (two-sided test, α = 0.05, power = 0.80, effect size f² = 0.15, 10 predictors). The minimum required sample size was 118, accounting for attrition; 132 patients were included in the study. The participants included patients with stomach (n = 6), bowel (n = 37), pancreas (n = 44), gallbladder (n = 8), bile duct (n = 30), and liver (n = 7) cancers. Eligibility criteria included the following: ≥18 years of age, a diagnosis of GI cancer, receipt of at least one chemotherapy cycle, and voluntary participation. The exclusion criteria were cognitive impairment, psychiatric disorders, and a second primary cancer. Chemotherapy regimens included first-generation cytotoxic agents (5-FU, oxaliplatin, irinotecan, gemcitabine, paclitaxel, bevacizumab, cisplatin, and capecitabine), second-generation targeted therapies (cetuximab, trastuzumab, ramucirumab, and perzumab), and third-generation immunotherapies (atezolizumab, nivolumab, and duvalumab). After excluding 5 incomplete questionnaires (1 bowel, 4 pancreatic cancers), 127 responses were analyzed. 2.2. Instruments 2.2.1 Participants’ Characteristics Participants’ sociodemographic characteristics included eight items: sex, age, religion, educational attainment, marital status, level of family support, employment status, and monthly income. Clinical characteristics were collected from electronic medical records, including cancer stage and metastasis, radiation therapy, anticancer drugs, number of chemotherapeutic sessions, and cancer duration. 2.2.2. Everyday Cognition The Everyday Cognition (ECog) scale is a 39-item, informant-based measure covering 6 domains: memory, language, visuospatial abilities, planning, organization, and divided attention [ 26 ]. The Korean ECog validated by Chung and Cho [ 27 ] was used with written permission. Participants rated their current daily functioning compared to their pre-chemotherapy status on a 4-point scale (1 = better/no change, 2 = occasionally worse, 3 = consistently a little worse, 4 = consistently much worse) [ 27 ]. “Don’t know” responses were excluded. The total score was calculated as the mean of the completed items (range: 1–4), with higher scores reflecting poorer cognition. The original scale demonstrated high reliability (test-retest r = 0.82) [ 26 ]. In this study, Cronbach’s α was 0.97 overall, and 0.89 for memory, 0.91 for language, 0.92 for visuospatial abilities, 0.91 for planning, 0.91 for organization, and 0.94 for divided attention. 2.2.3. Fatigue The Functional Assessment in Cancer Therapy-Fatigue (FACIT-F) was developed and validated by Cella et al. [ 28 ]. The FACIT-F covers physical fatigue (e.g., I feel tired), functional fatigue (e.g., I have trouble finishing things), emotional fatigue (e.g., frustration), and the social consequences of fatigue (e.g., it limits social activities). Permission to use the Korean version of the FACIT-F was obtained from the FACIT website ( http://www.facit.org/ ). The FACIT-F scale (version 4) is a 13-item scale that measures an individual's level of fatigue during daily activities over the past week and its impact. The level of fatigue was measured on a five-point Likert scale; the items were scored from 0 to 4 (4 = not at all fatigued to 0 = very much fatigued), with two positively worded items reversed. The scores range from 0 to 52, with higher scores reflecting less fatigue. Items were summed, multiplied by 13, and divided by the number of items that were actually answered to account for missing items. Reliability, as measured by Cronbach's ⍺, was 0.93 for the original version [ 28 ]. The reliability for the scale in this study was Cronbach's ⍺ = 0.93. 2.2.4. HPBs HPBs for digestive cancers were translated into Korean by Oh [ 29 ] based on the conceptual framework of Walker et al. [ 30 ]. We obtained permission from the authors to use the Korean version of the questionnaire. It contains 38 items in 6 domains: nutrition, physical activity, stress management, interpersonal relations, health responsibility, and spiritual growth. It uses a four-point response scale that indicates the respondents’ frequency of engaging in each behavior. Items are scored as follows: 1 = “never,” 2 = “sometimes,” 3 = “often,” and 4 = “routinely,” with higher scores indicating higher levels of HPBs, ranging from 38 to 152 points. In Oh’s study, the Cronbach's ⍺ was 0.886 [ 29 ]. The reliability for the composite scale in this study was Cronbach's ⍺ = 0.93, with ⍺ = 0.82 for nutrition, ⍺ = 0.81, physical activity, ⍺ = 0.74 for stress management, ⍺ = 0.89 for interpersonal relations, ⍺ = 0.71 for health responsibility, and ⍺ = 0.87 for spiritual growth. 2.2.5. QoL The Korean version of the Functional Assessment of Cancer Therapy-General (FACT-G) was used to assess the participants' QoL after obtaining consent via an online website ( http://www.facit.org/facitorg/questionnaires ). The FACT-G assesses physical, social, family, emotional, and functional well-being. The FACT-G is scored on a 5-point Likert scale (ranging from 0 = not at all to 4 = very much). The FACT-G summary scores range from 0 to 108, with higher scores indicating a better QoL. It contains specific questions to measure the respondent's health status over the past 7 days. In the study by Cella et al. [ 31 ], Cronbach's ⍺ was 0.87. The reliability of the composite scale in this study was Cronbach's ⍺ = 0.89, with ⍺ = 0.87 for physical well-being, ⍺ = 0.81 for social/family relationships, ⍺ = 0.83 for emotional well-being, and ⍺ = 0.87 for functional well-being. 2.3. Procedures Data were collected from 1 September to November 22, 2024. Before recruiting participants, the authors explained the purpose of the study to the oncologists, nursing directors, and head nurses of the oncology units or outpatient departments. After obtaining permission to conduct the study, a recruitment notice was posted in the oncology wards and outpatient clinics. The questionnaire consisted of a cover letter, informed consent form, and structured self-report instruments. The purpose and methods of the study were explained to the patients, and written informed consent was obtained. Before beginning the survey, participants were asked to carefully read the introduction, study objectives, and content. The non-collection of personally identifiable information, confidentiality, anonymity, and the right to withdraw at any time without reprisal were explained. The next page of the survey required written informed consent to participate. Participants were required to record their names and dates to confirm their voluntary participation in the study. The survey then proceeded with instructions on how to answer each question, designed to minimize missing data by addressing respondents’ queries. Each participant received a modest incentive of approximately 5. The survey took approximately 20 min to complete. 2.4. Ethical Considerations This study was conducted in accordance with the Declaration of Helsinki and the applicable institutional review board of Bundang CHA Medical Center (Approval No. CHAMC IRB 2024-07-025-003). At the commencement of the survey, the participants were informed of the IRB approval and the authors' contact information. The objectives of the study, its methods, participants' right to withdraw at any time without repercussions, and their right to privacy were thoroughly explained. Only patients who provided written informed consent were included in the study. All data were anonymized and securely stored for a period of 3 years before being discarded. 2.5. Data Analysis Data were analyzed using SPSS version 23 (IBM Corp., Armonk, NY, USA). The participants’ characteristics were summarized using descriptive statistics (frequency, percentage, mean, and standard deviation). Differences in cognition, fatigue, HPBs, and QoL according to participant characteristics were tested using the Mann-Whitney U test or Kruskal-Wallis test, with Bonferroni correction applied when normality (Kolmogorov-Smirnov test) was not satisfied. The associations between the main variables were examined using Spearman’s correlation analysis. The mediating effects of fatigue and HPBs on the relationship between cognition and QoL were evaluated using PROCESS Macro version 4.2 (model 4) with 50,000 bootstraps. Model assumptions were verified for residual normality (Kolmogorov-Smirnov), autocorrelation (Durbin-Watson), homoscedasticity (Breusch-Pagan), and multicollinearity (variance inflation factor). 3. Results 3.1. Participants’ Characteristics Among the 127 participants, 59.8% (n = 76) were males, and the mean age was 63.3 ± 8.7 years. Nearly half (48.8%, n = 62) were aged ≥ 65 years old. More than half (54.3%, n = 69) had no religious affiliation. Regarding education, 20.5% (n = 26) had less than a middle school education, whereas 30.7% (n = 39) had a college education or higher. Most participants were married (85.0%, n = 108), and 80.3% (n = 102) reported satisfaction with family support. Unemployment was high (75.6%, n = 96), and 44.9% (n = 57) reported a monthly income of less than 2 million won. Clinically, 46.5% (n = 59) of patients were diagnosed at stage 3, and 62.2% (n = 79) had metastasis. Approximately one-fourth (24.4%, n = 31) of the patients received radiation therapy, and 74.8% (n = 95) were treated with cytotoxic agents. The mean number of chemotherapy sessions was 16.5 ± 16.5, and the mean cancer duration was 15.2 ± 15.0 months (Table 1 ). Table 1 Participants' Characteristics ( N = 127) Characteristics Categories (Score range) n (%) or M ± SD Gender Male 76 (59.8) Female 51(40.2) Age (yr) 63.33 ± 8.66 ≤ 55 23 (18.1) 56 ~ 64 42 (33.1) ≥ 65 62 (48.8) Religion Yes 58 (45.7) No 69 (54.3) Education ≤Middle school 26 (20.5) High school 62 (48.8) ≥College 39 (30.7) Marital status Unmarried 12 (9.4) Married 108 (85.0) Divorced 7 (5.5) Family support Unsatisfied-Moderate 25 (19.7) Satisfied 102 (80.3) Job Yes 31 (24.4) No 96 (75.6) Monthly income (won) 4 million (3,000 $ ) 28 (22.0) Cancer stage 1 7 (5.5) 2 25 (19.7) 3 59 (46.5) 4 36 (28.3) Metastasis Yes 79 (62.2) No 48 (37.8) Radiation therapy Yes 31 (24.4) No 96 (75.6) Anticancer drugs Cytotoxic agent only 95 (74.8) Others 32 (25.2) Number of chemotherapy 16.53 ± 16.52 Cancer duration (months) 15.22 ± 15.01 M, mean; SD, standard deviation; Anticancer drug, Others: Targeted agent, Cancer immunotherapy, Combination therapy 3.2. Differences in Cognition, Fatigue, HPBs, and QoL According to Participants’ Characteristics The mean scores were 1.46 ± 0.53 for everyday cognition, 1.60 ± 0.94 for fatigue, 2.69 ± 0.52 HPBs, and 2.57 ± 0.65 for QoL were calculated. A total of 42.5% (n = 54) of participants met the criteria for amnestic mild cognitive impairment (aMCI, ≥ 1.41) and reported significantly poorer cognition, higher fatigue, lower HPBs, and reduced QoL compared to those without aMCI (all p < 0.001). Cognition was significantly poorer among the unemployed participants and those with lower incomes. Fatigue is higher in patients with metastases than in those treated with cytotoxic agents. HPBs varied by religion, marital status, family support, and income, with higher scores observed among participants with stronger family support and higher income. QoL was significantly higher among those with high family support and current employment (Tables 2 and 3 ). Table 2 Means of cognition, fatigue, heath promotion behavior and quality of life ( N = 127) Variables, Dimensions (Number of items) Score range M ± SD or n(%) Range (min-max) Cognition Fatigue Health promotion behavior Quality of Life M ± SD z M ± SD z M ± SD z M ± SD z Cognition (39) 1–4 1.46 ± 0.53 1.00-3.82 aMCI ≥ 1.41 54 (42.5) 1.00-1.38 1.94 ± 0.51 -9.63 * 1.93 ± 0.93 -3.64 * 2.45 ± 0.46 -4.71 * 2.29 ± 0.66 -3.96 * aMCI < 1.41 73 (57.5) 1.44–3.82 1.11 ± 0.10 1.36 ± 0.87 2.87 ± 0.49 2.77 ± 0.57 Memory (8) 1.50 ± 0.55 1.00-3.50 Language (9) 1.45 ± 0.57 1.00-3.89 Visuospatial function (7) 1.39 ± 0.61 1.00-3.67 Executive function: Planning (5) 1.35 ± 0.59 1.00–4.00 Executive function: Organization (6) 1.43 ± 0.60 1.00–4.00 Executive function: Divided attention (4) 1.72 ± 0.86 1.00–4.00 Fatigue (13) 0–4 1.60 ± 0.94 0.15-4.00 Health promotion behavior (38) 1–4 2.69 ± 0.52 1.34–3.71 Nutrition (10) 2.92 ± 0.55 1.50–3.90 Physical activity (4) 2.40 ± 0.85 1.00–4.00 Stress management (6) 2.38 ± 0.69 1.00–4.00 Interpersonal relations (5) 2.75 ± 0.79 1.00–4.00 Health responsibility (5) 2.46 ± 0.66 1.00–4.00 Spiritual growth (8) 2.89 ± 0.72 1.00–4.00 Quality of life (27) 0–4 2.57 ± 0.65 0.93–3.93 Physical well-being (7) 2.69 ± 0.94 0.14-4.00 Social/Family relationship (7) 2.30 ± 0.92 0.00–4.00 Emotional well-being (6) 2.78 ± 0.85 0.00–4.00 Functional well-being (7) 2.53 ± 0.95 0.43-4.00 M, mean; SD, standard deviation; aMCI, amnestic mild cognitive impairment; * p < .001 Table 3 Differences in cognition, fatigue, health promotion behavior, and quality of life according to participants’ characteristics ( N = 127) Variables Cognition Fatigue Health promotion behavior Quality of life Characteristics Categories M ± SD z or x 2 p M ± SD z or x 2 p M ± SD z or x 2 p M ± SD z or x 2 p Sex Men 1.45 ± 0.50 -0.79 .430 1.47 ± 0.89 -1.63 .103 2.66 ± 0.53 -0.73 .465 2.57 ± 0.67 -0.14 .888 Women 1.48 ± 0.56 1.78 ± 0.99 2.73 ± 0.50 2.56 ± 0.64 Age (yr) < 27 a 1.31 ± 0.43 4.30 .117 1.49 ± 0.97 0.85 .653 2.72 ± 0.43 0.02 .989 2.65 ± 0.60 1.01 .604 27 ~ ≤ 30 b 1.52 ± 0.67 1.62 ± 0.77 2.68 ± 0.54 2.48 ± 0.67 30 ~ ≤ 40 c 1.48 ± 0.46 1.63 ± 1.03 2.69 ± 0.54 2.60 ± 0.66 Religion Yes 1.46 ± 0.54 -0.23 .818 1.53 ± 0.94 -0.84 .402 2.80 ± 0.52 -2.32 .020 2.67 ± 0.61 -1.56 .119 No 1.46 ± 0.53 1.66 ± 0.94 2.60 ± 0.50 2.48 ± 0.68 Education Middle school a 1.39 ± 0.40 2.05 .360 1.63 ± 0.81 0.10 .608 2.63 ± 0.57 1.38 .502 2.43 ± 0.47 3.56 .169 High school b 1.50 ± 0.54 1.66 ± 1.01 2.67 ± 0.46 2.54 ± 0.68 ≥ College c 1.45 ± 0.61 1.49 ± 0.92 2.76 ± 0.57 2.71 ± 0.69 Marital status Unmarried a 1.49 ± 0.44 0.20 .904 1.76 ± 0.64 2.00 .369 2.28 ± 0.40 9.08 .011 2.16 ± 0.48 5.66 .059 Married b 1.47 ± 0.56 1.57 ± 0.96 2.74 ± 0.52 a < b 2.61 ± 0.65 Divorced c 1.35 ± 0.27 1.85 ± 1.06 2.66 ± 0.37 2.59 ± 0.70 Family support Unsatisfied-moderate 1.59 ± 0.68 1.12 .265 1.75 ± 0.99 -0.86 .389 2.44 ± 0.48 -2.73 .006 2.16 ± 0.54 -3.71 < .001 Satisfied 1.43 ± 0.49 1.56 ± 0.92 2.75 ± 0.51 2.67 ± 0.64 Job Yes 1.25 ± 0.36 -2.91 .004 1.39 ± 0.77 -1.10 .271 2.85 ± 0.42 -1.94 .052 2.78 ± 0.53 -2.18 .029 No 1.53 ± 0.56 1.67 ± 0.98 2.64 ± 0.54 2.50 ± 0.67 Monthly income c 1.73 ± 1.00 2.79 ± 0.48 a million won c 1.20 ± 0.25 1.35 ± 0.88 2.83 ± 0.47 2.72 ± 0.53 Cancer stage 1 a 1.15 ± 0.23 7.56 .056 1.20 ± 0.69 2.20 .531 2.77 ± 0.69 2.48 .478 2.74 ± 0.73 3.10 .372 2 b 1.46 ± 0.49 1.80 ± 1.06 2.78 ± 0.47 2.65 ± 0.65 3 c 1.40 ± 0.50 1.57 ± 0.87 2.71 ± 0.51 2.62 ± 0.66 4 d 1.63 ± 0.63 1.60 ± 0.99 2.58 ± 0.52 2.39 ± 0.61 Metastasis Yes 1.51 ± 0.57 -1.61 .107 1.74 ± 1.00 -1.98 .048 2.66 ± 0.49 -1.01 .314 2.48 ± 0.64 -1.74 .083 No 1.38 ± 0.46 1.37 ± 0.77 2.74 ± 0.56 2.71 ± 0.65 Radiation therapy Yes 1.54 ± 0.58 -0.88 .380 1.56 ± 0.90 -0.21 .838 2.72 ± 0.51 -0.17 .868 2.49 ± 0.53 -0.64 .520 No 1.44 ± 0.52 1.62 ± 0.95 2.68 ± 0.52 2.60 ± 0.69 Anticancer drugs Cytotoxic agent 1.48 ± 0.54 -1.06 .290 1.70 ± 0.95 -1.97 .049 2.71 ± 0.52 -0.58 .560 2.56 ± 0.65 -0.26 .792 Others 1.40 ± 0.52 1.32 ± 0.83 2.64 ± 0.50 2.60 ± 0.66 z-score calculated using the Mann–Whitney U test; x 2 calculated using the Kruskal–Wallis test; letters (a, b, c, d) presented for Bonferroni multiple comparison; M, mean; SD, standard deviation 3.3. Relationship between Cognition, Fatigue, HPBs, and QoL The findings, based on Spearman's correlation analysis, indicated a correlation between fatigue (r = 0.39, p < 0.001), HPBs (r = -0.43, p < 0.001), and QoL (r = -0.46, p < 0.001). Conversely, fatigue was negatively correlated with HPBs (r = -0.31, p < .001) and QoL (r = -0.57, p < 0.001). In contrast, HPBs positively correlated with QoL (r = 0.71, p < 0.001) (Table 4 ). Table 4 Relationships among cognition, fatigue, health promotion behavior, and quality of life ( N = 127) Variables Cognition Fatigue Health promotion behavior Quality of life r ( p ) r ( p ) r ( p ) r ( p ) Cognition Fatigue .39 (< .001) Health promotion behavior − .43 (< .001) − .31 (< .001) - Quality of life − .46 (< .001) − .57 (< .001) .71 (< .001) - r by Spearman’s correlation analysis 3.4. Mediating Effects of Fatigue and HPBs on the Relationship between Cognition and QoL Mediation analysis using Hayes’ PROCESS Macro indicated significant mediating roles of fatigue and HPBs in the relationship between cognition and QoL. The regression model satisfied the assumptions of normality, independence, and homoscedasticity with no evidence of multicollinearity. Cognition was positively associated with fatigue (B = 0.16, p = 0.003), which negatively affected QoL (B = -0.55, p < 0.001). Cognition also significantly influenced HPBs (B = -0.37, p < 0.001), which positively affected QoL (B = 0.46, p < 0.001). Bootstrapping revealed significant indirect effects through both fatigue (B = -0.09, 95% CI [-0.160, -0.031]) and HPBs (B = -0.17, 95% CI [-0.278, -0.094]). The final model explained 65% of the variance in QoL (Table 5; Fig. 1 ). Table 5. The mediating effects of fatigue and health promotion behavior in the relationship between cognition and quality of life ( N = 127) Dependent variable Independent variable Effect(B) se p R 2 Fatigue Cognition 0.16 0.05 .003 0.17 Health promotion behavior Cognition -0.37 0.08 <.001 0.23 Quality of Life Cognition -0.13 0.06 .022 0.65 Fatigue -0.55 0.09 <.001 Health promotion behavior 0.46 0.06 <.001 Total effect -0.39 0.07 <.001 Direct effect -0.13 0.06 .022 Indirect effect Effect(B) Boot se [95% CI ] Cognition→Fatigue→Quality of Life -0.09 0.03 [-0.160 -0.031] Cognition→Health promotion behavior→Quality of Life -0.17 0.05 [-0.278, -0.094] Abbreviations: se= standard error; LL= low level, UL=upper level; CI= confidence interval, Adjusted by covariates: Sex (Men=1); Religion, dummy variable (Yes=1), Job, dummy variable (Yes=1); Metastasis, dummy variable (Yes=1); Chemotherapy type, dummy variable (cytotoxic agent=1); Bootstrapping regression model for the parameters (number 4) with 50,000 bootstraps of the Process Macro 4. Discussion This study examined the levels of cognitive function, fatigue, HPBs, and QoL in patients with GI cancer receiving chemotherapy and verified the mediating effects of fatigue and HPBs on the relationship between cognitive function and QoL. In this study, the mean QoL score was 2.57 ± 0.65, consistent with the findings of previous studies using the same instrument [4]. Among the subdomains, the social/family domain scored the lowest (2.30 ± 0.92), consistent with our finding that patients with employment and those satisfied with family support reported higher QoL [4, 32]. Family and social support are associated with successful treatment, enhanced self-efficacy, and improved QoL [33], and can mitigate uncertainty and loneliness, positively influencing patients’ QoL [32]. Therefore, efforts to strengthen the social support systems for patients with GI cancer are essential. Cognitive function was identified as a major determinant of QoL, with 42.5% of participants classified as having mild amnestic cognitive impairment. The mean score for cognitive function was 1.46 ± 0.53, with memory (1.50 ± 0.55) being particularly impaired. This finding is consistent with those of prior studies reporting that approximately 38.8% of patients with GI cancer undergoing chemotherapy experience a decline in attention, memory, and executive functions [34]. Similarly, Oh and Kim [10,34] found that patients often experience forgetfulness, reduced work performance, and difficulties in daily activities, leading to frustration or job loss. In this study, cognitive decline was more pronounced among unemployed participants and those with lower incomes. Previous research has also shown that cognitive function is influenced by age, education, religious affiliation, occupation, income, family support, number of chemotherapy cycles, treatment duration, and type of chemotherapy [4, 6]. Moreover, the degree of impairment observed in this study was comparable to that typically seen in older adults, for whom cognitive decline is related to hippocampal atrophy caused by physiological stress and is strongly influenced by socioeconomic factors, such as education, income, and occupation [35]. These findings highlight the importance of routine cognitive assessments and supportive interventions for patients with cancer. HPBs play a significant role in the relationship between cognitive function and QoL. The mean score was 2.69 ± 0.52, with the highest subdomain being nutrition management (2.92 ± 0.55). In contrast, physical activity (2.40 ± 0.85), health responsibility (2.46 ± 0.66), and stress management (2.38 ± 0.69) were relatively low. These results are consistent with those of previous studies, which have shown that patients with GI cancer prioritize nutrition but score lower on physical activity and stress management [16, 21]. Furthermore, HPBs were significantly higher among participants with religious affiliation, marital status, greater family support, and higher income, consistent with previous findings showing that social support and socioeconomic resources are key factors that influence health behaviors [25, 36]. Therefore, programs targeting improvements in physical activity, health responsibility, and stress management, along with strengthening social support, are needed to enhance HPBs in patients with cancer. Fatigue is a key mediator of the relationship between cognitive function and QoL. The mean fatigue score was 1.60 ± 0.94, consistent with prior findings in patients with GI cancer [4, 25]. Fatigue significantly differed according to metastatic status and the use of cytotoxic agents, underscoring the importance of treatment-related factors in assessing fatigue. In this study, higher perceived cognitive impairment was associated with greater fatigue, lower HPBs, and, subsequently, lower QoL. This is consistent with previous findings showing that high fatigue levels reduce engagement in health behaviors, such as physical activity, adequate nutrition, stress management, and adherence to prescribed treatments [15, 22]. Conversely, interventions targeting fatigue reduction have been shown to improve physical activity, interpersonal relationships, and health behaviors, ultimately improving QoL [12, 37]. Similarly, improved HPBs are linked to reduced physiological stress responses and decreased fatigue [38]. Similar mechanisms have been proposed in other populations, such as patients with HIV, where lower memory scores are associated with higher treatment fatigue and poorer health-related QoL [39]. In addition, HPBs mediate the relationship between eHealth literacy and QoL in older adults [40]. Taken together, these findings suggest that cognitive decline in patients with cancer undergoing chemotherapy not only directly reduces their QoL, but also indirectly impairs it through increased fatigue and reduced HPBs. This highlights the need for integrated interventions that address cognitive function, fatigue management, and HPBs to improve the QoL of patients with GI cancer. 5. Limitations This study had some limitations. First, the cross-sectional design limited the ability to establish causal relationships among the variables. Longitudinal studies remain warranted to further examine the dynamic relationships among cognition, fatigue, HPBs, and QoL. Second, the use of convenience sampling may restrict the generalizability of the findings. Future studies using random sampling methods are recommended to enhance representativeness. Third, the participants were recruited from a specific region, which might have limited the external validity of the results. Broader sampling across diverse healthcare settings is required to strengthen the applicability of these results. 6. Conclusion This study demonstrated that cognitive decline among patients with GI cancer adversely affects their QoL through increased fatigue and reduced HPBs. These findings emphasize that cognitive impairment and fatigue are important treatment-related toxicities that require proactive supportive care. By identifying the mediating role of HPBs, this study provides an empirical basis for developing supportive interventions aimed at reducing fatigue, promoting self-management behaviors, and improving the QoL in this patient population. Declarations Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper. Ethics Approval This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of Bundang CHA Medical Center (Approval No. CHAMC IRB 2024-07-025-003). Consent to Participate Written informed consent was obtained from all individual participants included in the study. Consent to Publish Not applicable. Funding This research did not receive any financial support from funding agencies in the public, commercial, or not-for-profit sectors. Author Contribution B.L. wrote the original draft and performed methodology, investigation, software application, formal analysis, and data curation. S.K. supervised the study, contributed to data analysis, provision of resources and materials, and writing – review and editing.All authors reviewed and approved the final manuscript. H.-J.P. supervised the study, contributed to methodology, performed formal analysis, conceptualization, and data interpretation, and contributed to writing – review and editing. Acknowledgement The authors would like to thank all participants for their time and commitment to this study. Availability of Data and Materials The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. References National Cancer Information Center (2023) Cancer information service. https://www.cancer.go.kr/lay1/S1T289C290/contents.do National Cancer Center (2021) National Cancer Control Institute. https://www.cancer.go.kr/lay1/S1T648C650/contents.do Fillon M (2024) Osimertinib prolongs progression-free lung cancer survival after chemotherapy. CA Cancer J Clin 74(5):402–404. https://doi.org/10.3322/caac.21862 Kim SA, Han SH (2021) Impacts of fatigue, anxiety, depression, and cognitive function on the quality of life in gastrointestinal cancer patients receiving chemotherapy. East West Nurs Res 27(2):185–194. https://doi.org/10.14370/JEWNR.2021.27.2.185 Brianna, Lee SH (2023) Chemotherapy: how to reduce its adverse effects while maintaining the potency? Med Oncol 40(3):88. https://doi.org/10.1007/s12032-023-01954-6 Oh PJ, Lee JR (2016) Effect of cancer symptoms and fatigue on chemotherapy-related cognitive impairment and depression in people with gastrointestinal cancer. J Korean Acad Nurs 46(3):420–430. https://doi.org/10.4040/jkan.2016.46.3.420 Oh PJ, Lee JR (2016) Effect of cancer symptoms and fatigue on chemotherapy-related cognitive impairment and depression in people with gastrointestinal cancer. J Korean Acad Nurs 46(3):420–430. https://doi.org/10.4040/jkan.2016.46.3.420 Whittaker AL, George RP, O’Malley L (2022) Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis. Sci Rep 12:2135. https://doi.org/10.1038/s41598-022-05682-1 Schmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, et al (2016) Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv 10(2):302–311. https://doi.org/10.1007/s11764-015-0476-5 Krynetskiy E, Krynetskaia N, Rihawi D, Wieczerzak K, Ciummo V, Walker E (2013) Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment. Life Sci 93(17):605–610. https://doi.org/10.1016/j.lfs.2013.03.013 Oh PJ, Kim JH (2022) The experience of chemotherapy-related cognitive impairment in patients with cancer. Asian Oncol Nurs 22(1):1–10. https://doi.org/10.5388/aon.2022.22.1.1 Oppegaard KR, Mayo SJ, Armstrong TS, Anguera JA, Kober KM, Miaskowski C (2023) The multifactorial model of cancer-related cognitive impairment. Oncol Nurs Forum 50(2):135–147. https://doi.org/10.1188/23.ONF.135-147 Muthanna FMS, Hassan BAR, Karuppannan M, Ibrahim HK, Mohammed AH, Abdulrahman E (2023) Prevalence and impact of fatigue on quality of life of cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Asian Pac J Cancer Prev 24(3):769–781. https://doi.org/10.31557/APJCP.2023.24.3.769 NCCN (2018) NCCN Guidelines Version 1.2018 Cancer-related fatigue. https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf Vardy J, Dhillon HM, Pond GR, Rourke SB, Xu W, Dodd A, et al (2014) Cognitive function and fatigue after diagnosis of colorectal cancer. Ann Oncol 25(12):2404–2412. https://doi.org/10.1093/annonc/mdu448 Salmani S, Mousavi SH, Navardi S, Hosseinzadeh F, Pashaeypoor S (2022) The barriers and facilitators to health-promoting lifestyle behaviors among people with multiple sclerosis during the coronavirus disease 2019 pandemic: a content analysis study. BMC Neurol 22(1):490. https://doi.org/10.1186/s12883-022-03072-1 Yang EH, Kang JH (2024) Effects of family support and health promotion behaviors on quality of life of cancer patients after gastrectomy. Asian Oncol Nurs 24(4):196–204. https://doi.org/10.5388/aon.2024.24.4.196 Strebkova R (2020) Cancer-related fatigue in patients with oncological diseases: causes, prevalence, guidelines for assessment and management. Folia Med 62(4):679–689. https://doi.org/10.3897/folmed.62.e50517 Dun L, Xian-Yi W, Si-Ting H (2022) Effects of cognitive training and social support on cancer-related fatigue and quality of life in colorectal cancer survivors: a systematic review and meta-analysis. Integr Cancer Ther 21:15347354221081271. https://doi.org/10.1177/15347354221081271 Peixoto NMDSM, Peixoto TADSM, Pinto CAS, Santos CSVB (2021) Nursing intervention focusing on health promotion behaviors in adult cancer patients: a scoping review. Rev Esc Enferm USP 55:e03673. https://doi.org/10.1590/S1980-220X2019039403673 Lee ES, Park JS (2013) The comparison of health promotion behavior, post traumatic growth and quality of life according to stages of survivorship in patients with female genital neoplasm. J Korean Acad Adult Nurs 25(3):312–321. https://doi.org/10.7475/KJAN.2013.25.3.312 Kim MA, Lee HJ (2021) Impact of posttraumatic growth and health promoting behavior on quality of life in patients with gastrointestinal cancer. J Korean Acad Fundam Nurs 28(1):32–42. https://doi.org/10.7739/jkafn.2021.28.1.32 Kelly DL, Yang GS, Starkweather AR, Siangphoe U, Alexander-Delpech P, Lyon DE (2020) Relationships among fatigue, anxiety, depression, and pain and health-promoting lifestyle behaviors in women with early-stage breast cancer. Cancer Nurs 43(2):134–146. https://doi.org/10.1097/NCC.0000000000000677 Hsia HH, Tien Y, Lin YC, Huang HP (2024) Factors influencing health promotion lifestyle in female breast cancer survivors: the role of health behavior self-efficacy and associated factors. Semin Oncol Nurs 40(2):151622. https://doi.org/10.1016/j.soncn.2024.151622 Mols F, Schoormans D, de Hingh I, Oerlemans S, Husson O (2018) Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: prevalence, predictors, and impact on quality of life. Cancer 124(12):2621–2628. https://doi.org/10.1002/cncr.31369 Lee JR, Oh PJ (2016) Cognitive Decline and Quality of Life among Patients with Breast Cancer undergoing Chemotherapy: The Mediating Effect of Health Promotion Behavior. J Korean Acad Adult Nurs 28(2):202–212. https://doi.org/10.7469/kjan.2016.28.2.202 Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al (2008) The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology 22(4):531–544. https://doi.org/10.1037/0894-4105.22.4.531 Chung BY, Cho EJ (2012) Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncol Nurs 12(3):221–229. https://doi.org/10.5388/aon.2012.12.3.221 Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811–819 Oh PJ (1996) A structural model for health promotion and quality of life in people with cancer. J Nurses Acad Soc 26(3):632–652 Walker SN, Sechrist KR, Pender NJ (1987) The Health-Promoting Lifestyle Profile: development and psychometric characteristics. Nurs Res 36(2):76–81 Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579. https://doi.org/10.1200/JCO.1993.11.3.570 Zheng DN, Zheng XY, Luo QB, Cheng L, Cheng HD (2024) Study of the correlations between loneliness, disease uncertainty, and perceived social support among elderly patients with digestive tract tumors during treatment. Am J Transl Res 16(11):6758–6769 Sawma T, Choueiri P (2022) The influence of family functioning on the severity of fear of cancer recurrence: a cross-sectional study in a sample of Lebanese breast cancer survivors. Eur J Oncol Nurs 60:102169. https://doi.org/10.1016/j.ejon.2022.102169 Oh PJ, Moon SM (2019) Changes of cognitive function and fatigue following chemotherapy in patients with gastrointestinal cancer: a prospective controlled study. Asian Oncol Nurs 19(3):126–134. https://doi.org/10.5388/aon.2019.19.3.126 Burzynska AZ, Ganster DC, Fanning J, Salerno EA, Gothe NP, Voss MW, et al (2020) Occupational physical stress is negatively associated with hippocampal volume and memory in older adults. Front Hum Neurosci 14:266. https://doi.org/10.3389/fnhum.2020.00266 Tabrizi FM (2015) Health promoting behavior and its influencing factors in Iranian breast cancer survivors. Asian Pac J Cancer Prev 16(5):1729–1736. https://doi.org/10.7314/APJCP.2015.16.5.1729 Sadeghi E, Gozali N, Moghaddam Tabrizi F (2016) Effects of energy conservation strategies on cancer-related fatigue and health promotion lifestyle in breast cancer survivors: a randomized control trial. Asian Pac J Cancer Prev 17:4783–4790. https://doi.org/10.22034/APJCP.2016.17.10.4783 Liang M, Liu Z, Zhang R, Zhang N (2025) Effect of exercise based on the ACSM recommendations on fatigue in patients with digestive tumors: a meta-analysis of randomized controlled trials. J Cancer Surviv 2025:1–12. https://doi.org/10.1007/s11764-025-01397-6 Alcocer-Bruno C, Ferrer-Cascales R, Ruiz-Robledillo N, Clement-Carbonell V (2023) The mediation effect of treatment fatigue in the association between memory and health-related quality of life in men with HIV who have sex with men. Appl Neuropsychol Adult 2023:1–11. https://doi.org/10.1080/23279095.2023.2298375 Li S, Cui G, Yin Y, Wang S, Liu X, Chen L (2021) Health-promoting behaviors mediate the relationship between eHealth literacy and health-related quality of life among Chinese older adults: a cross-sectional study. Qual Life Res 30(8):2235–2243. https://doi.org/10.1007/s11136-021-02848-0 Additional Declarations No competing interests reported. Supplementary Files 20250824Figure1cognition.jpg Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7454615","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":531377640,"identity":"8df195dc-8ee6-4773-bb8a-c53d97be9db2","order_by":0,"name":"Boram Lee","email":"","orcid":"","institution":"CHA Bundang Medical Center","correspondingAuthor":false,"prefix":"","firstName":"Boram","middleName":"","lastName":"Lee","suffix":""},{"id":531377641,"identity":"cd56b6c3-85a4-4e33-9290-717309d225bb","order_by":1,"name":"Sunki Kim","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAsUlEQVRIiWNgGAWjYHACZoaECoYECPsA0VrOkKyFsY0ULfIzcg8bPJxnl8ffwPzwA8OZe4S1GNzIS05I3JZcLHGAzViC4UYxEVokcowPJG47kNhwgMGMgeFDAjEOA2mZcyBx/gH2b8RpYbiRY5wAtCJxwwEeoC03iNBicOaNsUHCseTEjYd5iiUSzhDjsPYcY8kfNXaJ8463b/zw4RgxDoMDZiAmScMoGAWjYBSMAtwAAFDQO2k/gsYAAAAAAElFTkSuQmCC","orcid":"","institution":"CHA University","correspondingAuthor":true,"prefix":"","firstName":"Sunki","middleName":"","lastName":"Kim","suffix":""},{"id":531377642,"identity":"078f1923-fe1c-49f3-bbf0-64630bdad925","order_by":2,"name":"Hye-Ja Park","email":"","orcid":"","institution":"CHA University","correspondingAuthor":false,"prefix":"","firstName":"Hye-Ja","middleName":"","lastName":"Park","suffix":""}],"badges":[],"createdAt":"2025-08-25 14:08:32","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7454615/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7454615/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":93942239,"identity":"46e83a97-b240-4485-84eb-26792ae3ea8a","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":186704,"visible":true,"origin":"","legend":"","description":"","filename":"20250901ManuscriptFinal.docx","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/1282aa30e5239588eadb1a0f.docx"},{"id":93943588,"identity":"7a6aed94-3116-47b5-9630-1f71ed7a3a68","added_by":"auto","created_at":"2025-10-20 13:55:46","extension":"json","order_by":1,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":5538,"visible":true,"origin":"","legend":"","description":"","filename":"3765fca9fa8d4f7cab2d5d16f01203ec.json","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/8700363e3c5301c06cee6047.json"},{"id":93942243,"identity":"9e73fcd1-a3bd-409f-ad50-8e0c90d52fc3","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"jpg","order_by":2,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":335788,"visible":true,"origin":"","legend":"","description":"","filename":"20250824Figure1cognition.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/a138490c54e267f45e72f898.jpg"},{"id":93942241,"identity":"46e48326-637f-4cd2-bbf4-5ea32508c87b","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"xml","order_by":3,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":169397,"visible":true,"origin":"","legend":"","description":"","filename":"3765fca9fa8d4f7cab2d5d16f01203ec1enriched.xml","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/6e47083d448fb2cdbd7dec44.xml"},{"id":93942240,"identity":"418f6eb4-8a35-44e3-b140-9a42fbb6252c","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"jpeg","order_by":4,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":335788,"visible":true,"origin":"","legend":"","description":"","filename":"floatimage1.jpeg","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/13879231652b917c2b302bac.jpeg"},{"id":93943589,"identity":"953d8d8e-226a-4b16-a024-6b7dbcf6ae41","added_by":"auto","created_at":"2025-10-20 13:55:46","extension":"png","order_by":5,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":151541,"visible":true,"origin":"","legend":"","description":"","filename":"Onlinefloatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/c8c5fe5adc03ae83badf16eb.png"},{"id":93942245,"identity":"389dc37c-1aa1-461a-8aab-c2a9f432b42a","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"xml","order_by":6,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":172159,"visible":true,"origin":"","legend":"","description":"","filename":"3765fca9fa8d4f7cab2d5d16f01203ec1structuring.xml","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/14cd5f2e5fc71ef109f6ec0f.xml"},{"id":93943590,"identity":"25941000-1bc2-49b6-be6f-a8cdfbb1c8b9","added_by":"auto","created_at":"2025-10-20 13:55:46","extension":"html","order_by":7,"title":"","display":"","copyAsset":false,"role":"acdc-reference","size":185458,"visible":true,"origin":"","legend":"","description":"","filename":"earlyproof.html","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/2245b9ea76875d86cc6e2812.html"},{"id":93942236,"identity":"086645ae-a14a-4dc7-a51a-70c91a8725c8","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":106732,"visible":true,"origin":"","legend":"\u003cp\u003eMediating effects of fatigue and HPBs in the relationship between cognition and QoL\u003c/p\u003e","description":"","filename":"1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/ddabd72255149e57628a42fc.jpg"},{"id":101513956,"identity":"3a28965a-d5a6-49db-a888-06ba8896d00c","added_by":"auto","created_at":"2026-01-30 15:40:53","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1637169,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/594d4977-6be2-4ca0-a45e-7f8cddc34037.pdf"},{"id":93942237,"identity":"b2732bd7-65f5-4682-a713-a9b820aa0f36","added_by":"auto","created_at":"2025-10-20 13:47:46","extension":"jpg","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":335788,"visible":true,"origin":"","legend":"","description":"","filename":"20250824Figure1cognition.jpg","url":"https://assets-eu.researchsquare.com/files/rs-7454615/v1/2b478f6b0a9ec46b773b984b.jpg"}],"financialInterests":"No competing interests reported.","formattedTitle":"Mediating effects of fatigue and health promotion behaviors on cognition and quality of life among patients with gastrointestinal cancer undergoing chemotherapy: a cross-sectional study","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eThe incidence of cancer-related mortality is increasing worldwide. For example, in Korea, gastrointestinal (GI) cancers, such as colorectal and gastric, remain highly prevalent, with colorectal, gastric, pancreatic, gallbladder, and bile duct cancers being the most common malignancies [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e]. The primary treatment options for GI cancers, either alone or in combination, include surgery, chemotherapy, radiotherapy, and targeted therapy. Recent advances in therapeutic technology have improved patient outcomes. Indeed, in Korea, for example, the 5-year relative survival rate of patients with cancer is increasing steadily to 72.9% [\u003cspan citationid=\"CR2\" class=\"CitationRef\"\u003e2\u003c/span\u003e, \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e]. Among these modalities, chemotherapy involves the systemic administration of cytotoxic drugs to destroy or inhibit the growth of cancer cells. Along with rapidly dividing cancer cells, first-generation chemotherapeutic agents also target and damage normal cells, leading to severe adverse effects such as neutropenia, alopecia, stomatitis, diarrhea, nausea, and vomiting. Meanwhile, despite having fewer side effects, second- and third-generation agents are only limited to specific malignancies [\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eApproximately 75% of patients with GI cancer undergoing chemotherapy experience systemic side effects, including bone marrow suppression, GI complications, alopecia, fatigue, immunosuppression, and neurotoxic manifestations\u0026mdash;such as cognitive impairment, peripheral neuropathy, depression, and anxiety, which reduce their quality of life (QoL) [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e]. In particular, chemotherapy-related cognitive impairment negatively affects patients\u0026rsquo; daily functioning and engagement in health-promoting behaviors (HPBs), making it a critical determinant of QoL [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e7\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eCancer-related cognitive impairment has been reported in up to 45% of cancer survivors [\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e8\u003c/span\u003e], with chemotherapy-induced impairment occurring in approximately one-third of all patients [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e7\u003c/span\u003e]. Although the underlying mechanisms are not fully understood, chemotherapy crosses the blood\u0026ndash;brain barrier, damages neuronal DNA, and induces neurotoxicity [\u003cspan citationid=\"CR10\" class=\"CitationRef\"\u003e9\u003c/span\u003e]. Cognitive decline is most prominent within the first year post-chemotherapy, with some patients experiencing recovery over time, while others face ongoing deficits [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e7\u003c/span\u003e, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e10\u003c/span\u003e]. Recent evidence suggests that cancer-related cognitive impairment arises not only from the direct neurotoxic effects of chemotherapy but also the interplay of social determinants of health, patient-specific factors, co-occurring symptoms, treatment-related factors, and other biological mechanisms [\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. Therefore, cancer-related cognitive impairment may be influenced by psychological distress, fatigue, hormonal alterations, and pharmacological factors [\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e7\u003c/span\u003e, \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e11\u003c/span\u003e]. This necessitates assessments and preventive strategies for cancer-related cognitive impairment [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e7\u003c/span\u003e, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e10\u003c/span\u003e, \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e11\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eCancer-related fatigue, another prevalent symptom, affects approximately 49% of survivors undergoing chemotherapy [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. The National Comprehensive Cancer Network defines cancer-related fatigue as a distressing, persistent, and subjective sense of physical, emotional, or cognitive tiredness associated with cancer or its treatment that is disproportionate to recent activities and interferes with daily functioning [\u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e13\u003c/span\u003e]. Cancer-related fatigue may persist beyond the active treatment phase, potentially lasting for two years post-therapy, and is associated with impaired QoL [\u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e14\u003c/span\u003e]. Fatigue has also been linked to depression, anxiety [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e], reduced HPBs [\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e15\u003c/span\u003e], and diminished QoL [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e17\u003c/span\u003e]. Conversely, alleviating fatigue contributes to improved QoL [\u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. Physical exercise, physiotherapy, cognitive-behavioral therapy, and sleep therapy, among other non-pharmacological interventions, have been shown to reduce cancer-related fatigue [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e17\u003c/span\u003e, \u003cspan citationid=\"CR19\" class=\"CitationRef\"\u003e18\u003c/span\u003e]. However, cancer-related fatigue is often underassessed and undertreated in clinical practice due to its subjective nature, highlighting the need for routine evaluation and management [\u003cspan citationid=\"CR18\" class=\"CitationRef\"\u003e17\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eHPBs refer to the proactive, self-directed health actions through which individuals take responsibility for their well-being [\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e19\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eAmong patients with cancer, HPBs are associated with recurrence prevention, physical and mental health maintenance, and overall well-being [\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e20\u003c/span\u003e]. In particular, patients with GI cancer require nutritional attention as part of their HPBs, along with exercise, stress management, interpersonal relationships, and adherence to healthy lifestyle practices [\u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e21\u003c/span\u003e]. HPBs not only reduces the risk of recurrence but also improves physical and psychological health, thereby enhancing the overall QoL [\u003cspan citationid=\"CR17\" class=\"CitationRef\"\u003e16\u003c/span\u003e, \u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e22\u003c/span\u003e, \u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e23\u003c/span\u003e].\u003c/p\u003e\u003cp\u003eCognitive function, fatigue, and HPBs are major predictors of survival and QoL in patients with GI cancer across the continuum of care from pre-chemotherapy to active treatment and long-term survivorship [\u003cspan citationid=\"CR24\" class=\"CitationRef\"\u003e23\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e24\u003c/span\u003e]. Specifically, cognitive decline is closely associated with fatigue [\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e], leading to an impaired QoL [\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e25\u003c/span\u003e]. Fatigue and HPBs are also strongly associated with QoL; exercise and other HPBs interventions have been shown to alleviate fatigue and enhance QoL [\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e12\u003c/span\u003e]. However, there is limited evidence regarding the mediating role of fatigue and HPBs in the relationship between cognitive function and QoL. Moreover, in clinical settings, patient-reported domains are often perceived as individual concerns, resulting in limited active interventions by healthcare providers.\u003c/p\u003e\u003cp\u003eTherefore, this study aimed to investigate the mediating effects of fatigue and HPBs on the relationship between cognitive function and QoL among patients with GI cancer undergoing chemotherapy.\u003c/p\u003e"},{"header":"2. Methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e\u003ch2\u003e2.1. Study Design and Participants\u003c/h2\u003e\u003cp\u003eThis cross-sectional descriptive study employed a quantitative mediation analysis to examine the mediating roles of fatigue and HPBs between cognition and QoL in patients with GI cancer receiving chemotherapy. Data were collected from outpatient and oncology units at a university-affiliated cancer center in Gyeonggi-do, Republic of Korea. Sample size was estimated using G*Power 3.1.9.7 for linear multiple regression (two-sided test, α\u0026thinsp;=\u0026thinsp;0.05, power\u0026thinsp;=\u0026thinsp;0.80, effect size f\u0026sup2; = 0.15, 10 predictors).\u003c/p\u003e\u003cp\u003eThe minimum required sample size was 118, accounting for attrition; 132 patients were included in the study. The participants included patients with stomach (n\u0026thinsp;=\u0026thinsp;6), bowel (n\u0026thinsp;=\u0026thinsp;37), pancreas (n\u0026thinsp;=\u0026thinsp;44), gallbladder (n\u0026thinsp;=\u0026thinsp;8), bile duct (n\u0026thinsp;=\u0026thinsp;30), and liver (n\u0026thinsp;=\u0026thinsp;7) cancers. Eligibility criteria included the following: \u0026ge;18 years of age, a diagnosis of GI cancer, receipt of at least one chemotherapy cycle, and voluntary participation. The exclusion criteria were cognitive impairment, psychiatric disorders, and a second primary cancer. Chemotherapy regimens included first-generation cytotoxic agents (5-FU, oxaliplatin, irinotecan, gemcitabine, paclitaxel, bevacizumab, cisplatin, and capecitabine), second-generation targeted therapies (cetuximab, trastuzumab, ramucirumab, and perzumab), and third-generation immunotherapies (atezolizumab, nivolumab, and duvalumab). After excluding 5 incomplete questionnaires (1 bowel, 4 pancreatic cancers), 127 responses were analyzed.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec4\" class=\"Section2\"\u003e\u003ch2\u003e2.2. Instruments\u003c/h2\u003e\u003cdiv id=\"Sec5\" class=\"Section3\"\u003e\u003ch2\u003e2.2.1 Participants\u0026rsquo; Characteristics\u003c/h2\u003e\u003cp\u003eParticipants\u0026rsquo; sociodemographic characteristics included eight items: sex, age, religion, educational attainment, marital status, level of family support, employment status, and monthly income. Clinical characteristics were collected from electronic medical records, including cancer stage and metastasis, radiation therapy, anticancer drugs, number of chemotherapeutic sessions, and cancer duration.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec6\" class=\"Section3\"\u003e\u003ch2\u003e2.2.2. Everyday Cognition\u003c/h2\u003e\u003cp\u003eThe Everyday Cognition (ECog) scale is a 39-item, informant-based measure covering 6 domains: memory, language, visuospatial abilities, planning, organization, and divided attention [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]. The Korean ECog validated by Chung and Cho [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e] was used with written permission.\u003c/p\u003e\u003cp\u003eParticipants rated their current daily functioning compared to their pre-chemotherapy status on a 4-point scale (1\u0026thinsp;=\u0026thinsp;better/no change, 2\u0026thinsp;=\u0026thinsp;occasionally worse, 3\u0026thinsp;=\u0026thinsp;consistently a little worse, 4\u0026thinsp;=\u0026thinsp;consistently much worse) [\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e]. \u0026ldquo;Don\u0026rsquo;t know\u0026rdquo; responses were excluded. The total score was calculated as the mean of the completed items (range: 1\u0026ndash;4), with higher scores reflecting poorer cognition. The original scale demonstrated high reliability (test-retest r\u0026thinsp;=\u0026thinsp;0.82) [\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e]. In this study, Cronbach\u0026rsquo;s α was 0.97 overall, and 0.89 for memory, 0.91 for language, 0.92 for visuospatial abilities, 0.91 for planning, 0.91 for organization, and 0.94 for divided attention.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec7\" class=\"Section3\"\u003e\u003ch2\u003e2.2.3. Fatigue\u003c/h2\u003e\u003cp\u003eThe Functional Assessment in Cancer Therapy-Fatigue (FACIT-F) was developed and validated by Cella et al. [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. The FACIT-F covers physical fatigue (e.g., I feel tired), functional fatigue (e.g., I have trouble finishing things), emotional fatigue (e.g., frustration), and the social consequences of fatigue (e.g., it limits social activities). Permission to use the Korean version of the FACIT-F was obtained from the FACIT website (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://www.facit.org/\u003c/span\u003e\u003cspan address=\"http://www.facit.org/\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e). The FACIT-F scale (version 4) is a 13-item scale that measures an individual's level of fatigue during daily activities over the past week and its impact. The level of fatigue was measured on a five-point Likert scale; the items were scored from 0 to 4 (4\u0026thinsp;=\u0026thinsp;not at all fatigued to 0\u0026thinsp;=\u0026thinsp;very much fatigued), with two positively worded items reversed. The scores range from 0 to 52, with higher scores reflecting less fatigue. Items were summed, multiplied by 13, and divided by the number of items that were actually answered to account for missing items. Reliability, as measured by Cronbach's ⍺, was 0.93 for the original version [\u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e]. The reliability for the scale in this study was Cronbach's ⍺ = 0.93.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec8\" class=\"Section3\"\u003e\u003ch2\u003e2.2.4. HPBs\u003c/h2\u003e\u003cp\u003eHPBs for digestive cancers were translated into Korean by Oh [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e] based on the conceptual framework of Walker et al. [\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e]. We obtained permission from the authors to use the Korean version of the questionnaire. It contains 38 items in 6 domains: nutrition, physical activity, stress management, interpersonal relations, health responsibility, and spiritual growth. It uses a four-point response scale that indicates the respondents\u0026rsquo; frequency of engaging in each behavior. Items are scored as follows: 1 = \u0026ldquo;never,\u0026rdquo; 2 = \u0026ldquo;sometimes,\u0026rdquo; 3 = \u0026ldquo;often,\u0026rdquo; and 4 = \u0026ldquo;routinely,\u0026rdquo; with higher scores indicating higher levels of HPBs, ranging from 38 to 152 points. In Oh\u0026rsquo;s study, the Cronbach's ⍺ was 0.886 [\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e]. The reliability for the composite scale in this study was Cronbach's ⍺ = 0.93, with ⍺ = 0.82 for nutrition, ⍺ = 0.81, physical activity, ⍺ = 0.74 for stress management, ⍺ = 0.89 for interpersonal relations, ⍺ = 0.71 for health responsibility, and ⍺ = 0.87 for spiritual growth.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec9\" class=\"Section3\"\u003e\u003ch2\u003e2.2.5. QoL\u003c/h2\u003e\u003cp\u003eThe Korean version of the Functional Assessment of Cancer Therapy-General (FACT-G) was used to assess the participants' QoL after obtaining consent via an online website (\u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttp://www.facit.org/facitorg/questionnaires\u003c/span\u003e\u003cspan address=\"http://www.facit.org/facitorg/questionnaires\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e). The FACT-G assesses physical, social, family, emotional, and functional well-being. The FACT-G is scored on a 5-point Likert scale (ranging from 0\u0026thinsp;=\u0026thinsp;not at all to 4\u0026thinsp;=\u0026thinsp;very much). The FACT-G summary scores range from 0 to 108, with higher scores indicating a better QoL. It contains specific questions to measure the respondent's health status over the past 7 days. In the study by Cella et al. [\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e], Cronbach's ⍺ was 0.87. The reliability of the composite scale in this study was Cronbach's ⍺ = 0.89, with ⍺ = 0.87 for physical well-being, ⍺ = 0.81 for social/family relationships, ⍺ = 0.83 for emotional well-being, and ⍺ = 0.87 for functional well-being.\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv id=\"Sec10\" class=\"Section2\"\u003e\u003ch2\u003e2.3. Procedures\u003c/h2\u003e\u003cp\u003eData were collected from 1 September to November 22, 2024. Before recruiting participants, the authors explained the purpose of the study to the oncologists, nursing directors, and head nurses of the oncology units or outpatient departments. After obtaining permission to conduct the study, a recruitment notice was posted in the oncology wards and outpatient clinics. The questionnaire consisted of a cover letter, informed consent form, and structured self-report instruments. The purpose and methods of the study were explained to the patients, and written informed consent was obtained. Before beginning the survey, participants were asked to carefully read the introduction, study objectives, and content. The non-collection of personally identifiable information, confidentiality, anonymity, and the right to withdraw at any time without reprisal were explained. The next page of the survey required written informed consent to participate. Participants were required to record their names and dates to confirm their voluntary participation in the study. The survey then proceeded with instructions on how to answer each question, designed to minimize missing data by addressing respondents\u0026rsquo; queries. Each participant received a modest incentive of approximately 5. The survey took approximately 20 min to complete.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec11\" class=\"Section2\"\u003e\u003ch2\u003e2.4. Ethical Considerations\u003c/h2\u003e\u003cp\u003e This study was conducted in accordance with the Declaration of Helsinki and the applicable institutional review board of Bundang CHA Medical Center (Approval No. CHAMC IRB 2024-07-025-003). At the commencement of the survey, the participants were informed of the IRB approval and the authors' contact information. The objectives of the study, its methods, participants' right to withdraw at any time without repercussions, and their right to privacy were thoroughly explained. Only patients who provided written informed consent were included in the study. All data were anonymized and securely stored for a period of 3 years before being discarded.\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec12\" class=\"Section2\"\u003e\u003ch2\u003e2.5. Data Analysis\u003c/h2\u003e\u003cp\u003eData were analyzed using SPSS version 23 (IBM Corp., Armonk, NY, USA). The participants\u0026rsquo; characteristics were summarized using descriptive statistics (frequency, percentage, mean, and standard deviation). Differences in cognition, fatigue, HPBs, and QoL according to participant characteristics were tested using the Mann-Whitney \u003cem\u003eU\u003c/em\u003e test or Kruskal-Wallis test, with Bonferroni correction applied when normality (Kolmogorov-Smirnov test) was not satisfied. The associations between the main variables were examined using Spearman\u0026rsquo;s correlation analysis. The mediating effects of fatigue and HPBs on the relationship between cognition and QoL were evaluated using PROCESS Macro version 4.2 (model 4) with 50,000 bootstraps. Model assumptions were verified for residual normality (Kolmogorov-Smirnov), autocorrelation (Durbin-Watson), homoscedasticity (Breusch-Pagan), and multicollinearity (variance inflation factor).\u003c/p\u003e\u003c/div\u003e"},{"header":"3. Results","content":"\u003cdiv id=\"Sec14\" class=\"Section2\"\u003e\u003ch2\u003e3.1. Participants\u0026rsquo; Characteristics\u003c/h2\u003e\u003cp\u003eAmong the 127 participants, 59.8% (n\u0026thinsp;=\u0026thinsp;76) were males, and the mean age was 63.3\u0026thinsp;\u0026plusmn;\u0026thinsp;8.7 years. Nearly half (48.8%, n\u0026thinsp;=\u0026thinsp;62) were aged\u0026thinsp;\u0026ge;\u0026thinsp;65 years old. More than half (54.3%, n\u0026thinsp;=\u0026thinsp;69) had no religious affiliation. Regarding education, 20.5% (n\u0026thinsp;=\u0026thinsp;26) had less than a middle school education, whereas 30.7% (n\u0026thinsp;=\u0026thinsp;39) had a college education or higher. Most participants were married (85.0%, n\u0026thinsp;=\u0026thinsp;108), and 80.3% (n\u0026thinsp;=\u0026thinsp;102) reported satisfaction with family support. Unemployment was high (75.6%, n\u0026thinsp;=\u0026thinsp;96), and 44.9% (n\u0026thinsp;=\u0026thinsp;57) reported a monthly income of less than 2\u0026nbsp;million won. Clinically, 46.5% (n\u0026thinsp;=\u0026thinsp;59) of patients were diagnosed at stage 3, and 62.2% (n\u0026thinsp;=\u0026thinsp;79) had metastasis. Approximately one-fourth (24.4%, n\u0026thinsp;=\u0026thinsp;31) of the patients received radiation therapy, and 74.8% (n\u0026thinsp;=\u0026thinsp;95) were treated with cytotoxic agents. The mean number of chemotherapy sessions was 16.5\u0026thinsp;\u0026plusmn;\u0026thinsp;16.5, and the mean cancer duration was 15.2\u0026thinsp;\u0026plusmn;\u0026thinsp;15.0 months (Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e).\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eParticipants' Characteristics (\u003cem\u003eN\u003c/em\u003e\u0026thinsp;=\u0026thinsp;127)\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"3\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCharacteristics\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCategories (Score range)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003en (%) or M\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eGender\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eMale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e76 (59.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eFemale\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e51(40.2)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAge (yr)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e63.33\u0026thinsp;\u0026plusmn;\u0026thinsp;8.66\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026le;\u0026thinsp;55\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e23 (18.1)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e56\u0026thinsp;~\u0026thinsp;64\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e42 (33.1)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026ge;\u0026thinsp;65\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e62 (48.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eReligion\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e58 (45.7)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e69 (54.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eEducation\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026le;Middle school\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e26 (20.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eHigh school\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e62 (48.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026ge;College\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e39 (30.7)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMarital status\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eUnmarried\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e12 (9.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eMarried\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e108 (85.0)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eDivorced\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e7 (5.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFamily support\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eUnsatisfied-Moderate\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e25 (19.7)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eSatisfied\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e102 (80.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eJob\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e31 (24.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e96 (75.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMonthly income (won)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;2\u0026nbsp;million (1,500\u003cspan\u003e$\u003c/span\u003e)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e57 (44.9)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2\u0026ndash;4\u0026nbsp;million\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e42 (33.1)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026gt;\u0026thinsp;4\u0026nbsp;million (3,000\u003cspan\u003e$\u003c/span\u003e)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e28 (22.0)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer stage\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e7 (5.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e25 (19.7)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e59 (46.5)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e36 (28.3)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMetastasis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e79 (62.2)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e48 (37.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eRadiation therapy\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e31 (24.4)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e96 (75.6)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAnticancer drugs\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCytotoxic agent only\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e95 (74.8)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eOthers\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e32 (25.2)\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eNumber of chemotherapy\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e16.53\u0026thinsp;\u0026plusmn;\u0026thinsp;16.52\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer duration (months)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e15.22\u0026thinsp;\u0026plusmn;\u0026thinsp;15.01\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c3\" namest=\"c1\"\u003e\u003cp\u003eM, mean; SD, standard deviation; Anticancer drug, Others: Targeted agent, Cancer immunotherapy, Combination therapy\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec15\" class=\"Section2\"\u003e\u003ch2\u003e3.2. Differences in Cognition, Fatigue, HPBs, and QoL According to Participants\u0026rsquo; Characteristics\u003c/h2\u003e\u003cp\u003eThe mean scores were 1.46\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53 for everyday cognition, 1.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.94 for fatigue, 2.69\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52 HPBs, and 2.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.65 for QoL were calculated. A total of 42.5% (n\u0026thinsp;=\u0026thinsp;54) of participants met the criteria for amnestic mild cognitive impairment (aMCI, \u0026ge;\u0026thinsp;1.41) and reported significantly poorer cognition, higher fatigue, lower HPBs, and reduced QoL compared to those without aMCI (all \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001).\u003c/p\u003e\u003cp\u003eCognition was significantly poorer among the unemployed participants and those with lower incomes. Fatigue is higher in patients with metastases than in those treated with cytotoxic agents. HPBs varied by religion, marital status, family support, and income, with higher scores observed among participants with stronger family support and higher income. QoL was significantly higher among those with high family support and current employment (Tables\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e and \u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e3\u003c/span\u003e).\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eMeans of cognition, fatigue, heath promotion behavior and quality of life (\u003cem\u003eN\u003c/em\u003e\u0026thinsp;=\u0026thinsp;127)\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"14\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c10\" colnum=\"10\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c11\" colnum=\"11\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c12\" colnum=\"12\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c13\" colnum=\"13\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c14\" colnum=\"14\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e\u003cp\u003eVariables, Dimensions\u003c/p\u003e\u003cp\u003e(Number of items)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"3\" morerows=\"1\" nameend=\"c4\" namest=\"c2\" rowspan=\"2\"\u003e\u003cp\u003eScore range\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\" morerows=\"1\" rowspan=\"2\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD or n(%)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c6\" morerows=\"1\" rowspan=\"2\"\u003e\u003cp\u003eRange\u003c/p\u003e\u003cp\u003e(min-max)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c8\" namest=\"c7\"\u003e\u003cp\u003eCognition\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c10\" namest=\"c9\"\u003e\u003cp\u003eFatigue\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c12\" namest=\"c11\"\u003e\u003cp\u003eHealth promotion behavior\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"2\" nameend=\"c14\" namest=\"c13\"\u003e\u003cp\u003eQuality of Life\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c7\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c8\"\u003e\u003cp\u003ez\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c9\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c10\"\u003e\u003cp\u003ez\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c11\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c12\"\u003e\u003cp\u003ez\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c13\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c14\"\u003e\u003cp\u003ez\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eCognition\u003c/b\u003e (39)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u003cp\u003e1\u0026ndash;4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.46\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00-3.82\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eaMCI\u0026thinsp;\u0026ge;\u0026thinsp;1.41\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e54 (42.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00-1.38\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e1.94\u0026thinsp;\u0026plusmn;\u0026thinsp;0.51\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e-9.63\u003csup\u003e*\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e1.93\u0026thinsp;\u0026plusmn;\u0026thinsp;0.93\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-3.64\u003csup\u003e*\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e2.45\u0026thinsp;\u0026plusmn;\u0026thinsp;0.46\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e-4.71\u003csup\u003e*\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e2.29\u0026thinsp;\u0026plusmn;\u0026thinsp;0.66\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e-3.96\u003csup\u003e*\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eaMCI\u0026thinsp;\u0026lt;\u0026thinsp;1.41\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e73 (57.5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.44\u0026ndash;3.82\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e1.11\u0026thinsp;\u0026plusmn;\u0026thinsp;0.10\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e1.36\u0026thinsp;\u0026plusmn;\u0026thinsp;0.87\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e2.87\u0026thinsp;\u0026plusmn;\u0026thinsp;0.49\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e2.77\u0026thinsp;\u0026plusmn;\u0026thinsp;0.57\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMemory (8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.50\u0026thinsp;\u0026plusmn;\u0026thinsp;0.55\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00-3.50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eLanguage (9)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.45\u0026thinsp;\u0026plusmn;\u0026thinsp;0.57\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00-3.89\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eVisuospatial function (7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.39\u0026thinsp;\u0026plusmn;\u0026thinsp;0.61\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00-3.67\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eExecutive function: Planning (5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.35\u0026thinsp;\u0026plusmn;\u0026thinsp;0.59\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"2\" nameend=\"c2\" namest=\"c1\"\u003e\u003cp\u003eExecutive function: Organization (6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"2\" nameend=\"c4\" namest=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.43\u0026thinsp;\u0026plusmn;\u0026thinsp;0.60\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c3\" namest=\"c1\"\u003e\u003cp\u003eExecutive function: Divided attention (4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.72\u0026thinsp;\u0026plusmn;\u0026thinsp;0.86\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eFatigue\u003c/b\u003e (13)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u003cp\u003e0\u0026ndash;4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e1.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.94\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.15-4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eHealth promotion behavior\u003c/b\u003e (38)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u003cp\u003e1\u0026ndash;4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.69\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.34\u0026ndash;3.71\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eNutrition (10)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.92\u0026thinsp;\u0026plusmn;\u0026thinsp;0.55\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.50\u0026ndash;3.90\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePhysical activity (4)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.40\u0026thinsp;\u0026plusmn;\u0026thinsp;0.85\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eStress management (6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.38\u0026thinsp;\u0026plusmn;\u0026thinsp;0.69\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eInterpersonal relations (5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.75\u0026thinsp;\u0026plusmn;\u0026thinsp;0.79\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHealth responsibility (5)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.46\u0026thinsp;\u0026plusmn;\u0026thinsp;0.66\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSpiritual growth (8)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.89\u0026thinsp;\u0026plusmn;\u0026thinsp;0.72\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003e\u003cb\u003eQuality of life\u003c/b\u003e (27)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u003cp\u003e0\u0026ndash;4\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.65\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.93\u0026ndash;3.93\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003ePhysical well-being (7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.69\u0026thinsp;\u0026plusmn;\u0026thinsp;0.94\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.14-4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSocial/Family relationship (7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.30\u0026thinsp;\u0026plusmn;\u0026thinsp;0.92\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eEmotional well-being (6)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.78\u0026thinsp;\u0026plusmn;\u0026thinsp;0.85\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.00\u0026ndash;4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFunctional well-being (7)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"3\" nameend=\"c4\" namest=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e2.53\u0026thinsp;\u0026plusmn;\u0026thinsp;0.95\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e0.43-4.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003cp\u003eM, mean; SD, standard deviation; aMCI, amnestic mild cognitive impairment; \u003csup\u003e*\u003c/sup\u003e\u003cb\u003ep\u003c/b\u003e\u0026thinsp;\u0026lt;\u0026thinsp;.001\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eDifferences in cognition, fatigue, health promotion behavior, and quality of life according to participants\u0026rsquo; characteristics (\u003cem\u003eN\u003c/em\u003e\u0026thinsp;=\u0026thinsp;127)\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"15\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c10\" colnum=\"10\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c11\" colnum=\"11\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c12\" colnum=\"12\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c13\" colnum=\"13\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c14\" colnum=\"14\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c15\" colnum=\"15\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eVariables\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/th\u003e\u003cth align=\"left\" colspan=\"3\" nameend=\"c5\" namest=\"c3\"\u003e\u003cp\u003eCognition\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"3\" nameend=\"c8\" namest=\"c6\"\u003e\u003cp\u003eFatigue\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"3\" nameend=\"c11\" namest=\"c9\"\u003e\u003cp\u003eHealth promotion behavior\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"3\" nameend=\"c14\" namest=\"c12\"\u003e\u003cp\u003eQuality of life\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCharacteristics\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCategories\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u003cp\u003ez or x\u003csup\u003e2\u003c/sup\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u003cp\u003e\u003cem\u003ep\u003c/em\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c6\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c7\"\u003e\u003cp\u003ez or x\u003csup\u003e2\u003c/sup\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c8\"\u003e\u003cp\u003e\u003cem\u003ep\u003c/em\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c9\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c10\"\u003e\u003cp\u003ez or x\u003csup\u003e2\u003c/sup\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c11\"\u003e\u003cp\u003e\u003cem\u003ep\u003c/em\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c12\"\u003e\u003cp\u003eM\u0026thinsp;\u0026plusmn;\u0026thinsp;SD\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c13\"\u003e\u003cp\u003ez or x\u003csup\u003e2\u003c/sup\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c14\"\u003e\u003cp\u003e\u003cem\u003ep\u003c/em\u003e\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eSex\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eMen\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.45\u0026thinsp;\u0026plusmn;\u0026thinsp;0.50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-0.79\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.430\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.47\u0026thinsp;\u0026plusmn;\u0026thinsp;0.89\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-1.63\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.103\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.66\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-0.73\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.465\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.67\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-0.14\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.888\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eWomen\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.78\u0026thinsp;\u0026plusmn;\u0026thinsp;0.99\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.73\u0026thinsp;\u0026plusmn;\u0026thinsp;0.50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.56\u0026thinsp;\u0026plusmn;\u0026thinsp;0.64\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAge (yr)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;27 \u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.31\u0026thinsp;\u0026plusmn;\u0026thinsp;0.43\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e4.30\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.117\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.49\u0026thinsp;\u0026plusmn;\u0026thinsp;0.97\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.85\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.653\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.72\u0026thinsp;\u0026plusmn;\u0026thinsp;0.43\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e0.02\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.989\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.65\u0026thinsp;\u0026plusmn;\u0026thinsp;0.60\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e1.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.604\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e27\u0026thinsp;~\u0026thinsp;\u0026le;\u0026thinsp;30 \u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.52\u0026thinsp;\u0026plusmn;\u0026thinsp;0.67\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.62\u0026thinsp;\u0026plusmn;\u0026thinsp;0.77\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.68\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.67\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e30\u0026thinsp;~\u0026thinsp;\u0026le;\u0026thinsp;40 \u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.46\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.63\u0026thinsp;\u0026plusmn;\u0026thinsp;1.03\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.69\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.66\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eReligion\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.46\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-0.23\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.818\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.53\u0026thinsp;\u0026plusmn;\u0026thinsp;0.94\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-0.84\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.402\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.80\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-2.32\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.020\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.67\u0026thinsp;\u0026plusmn;\u0026thinsp;0.61\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-1.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.119\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.46\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.66\u0026thinsp;\u0026plusmn;\u0026thinsp;0.94\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.68\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eEducation\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eMiddle school \u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.39\u0026thinsp;\u0026plusmn;\u0026thinsp;0.40\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e2.05\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.360\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.63\u0026thinsp;\u0026plusmn;\u0026thinsp;0.81\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e0.10\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.608\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.63\u0026thinsp;\u0026plusmn;\u0026thinsp;0.57\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e1.38\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.502\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.43\u0026thinsp;\u0026plusmn;\u0026thinsp;0.47\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e3.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.169\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eHigh school \u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.50\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.66\u0026thinsp;\u0026plusmn;\u0026thinsp;1.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.67\u0026thinsp;\u0026plusmn;\u0026thinsp;0.46\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.54\u0026thinsp;\u0026plusmn;\u0026thinsp;0.68\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026ge; College \u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.45\u0026thinsp;\u0026plusmn;\u0026thinsp;0.61\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.49\u0026thinsp;\u0026plusmn;\u0026thinsp;0.92\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.76\u0026thinsp;\u0026plusmn;\u0026thinsp;0.57\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.71\u0026thinsp;\u0026plusmn;\u0026thinsp;0.69\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMarital status\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eUnmarried \u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.49\u0026thinsp;\u0026plusmn;\u0026thinsp;0.44\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e0.20\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.904\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.76\u0026thinsp;\u0026plusmn;\u0026thinsp;0.64\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e2.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.369\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.28\u0026thinsp;\u0026plusmn;\u0026thinsp;0.40\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e9.08\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.011\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.16\u0026thinsp;\u0026plusmn;\u0026thinsp;0.48\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e5.66\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.059\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eMarried \u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.47\u0026thinsp;\u0026plusmn;\u0026thinsp;0.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.96\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.74\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003ea\u0026thinsp;\u0026lt;\u0026thinsp;b\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.61\u0026thinsp;\u0026plusmn;\u0026thinsp;0.65\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eDivorced \u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.35\u0026thinsp;\u0026plusmn;\u0026thinsp;0.27\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.85\u0026thinsp;\u0026plusmn;\u0026thinsp;1.06\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.66\u0026thinsp;\u0026plusmn;\u0026thinsp;0.37\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.59\u0026thinsp;\u0026plusmn;\u0026thinsp;0.70\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFamily support\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eUnsatisfied-moderate\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.59\u0026thinsp;\u0026plusmn;\u0026thinsp;0.68\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e1.12\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.265\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.75\u0026thinsp;\u0026plusmn;\u0026thinsp;0.99\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-0.86\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.389\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.44\u0026thinsp;\u0026plusmn;\u0026thinsp;0.48\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-2.73\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.006\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.16\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-3.71\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;.001\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eSatisfied\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.43\u0026thinsp;\u0026plusmn;\u0026thinsp;0.49\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.56\u0026thinsp;\u0026plusmn;\u0026thinsp;0.92\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.75\u0026thinsp;\u0026plusmn;\u0026thinsp;0.51\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.67\u0026thinsp;\u0026plusmn;\u0026thinsp;0.64\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eJob\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.25\u0026thinsp;\u0026plusmn;\u0026thinsp;0.36\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-2.91\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.004\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.39\u0026thinsp;\u0026plusmn;\u0026thinsp;0.77\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-1.10\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.271\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.85\u0026thinsp;\u0026plusmn;\u0026thinsp;0.42\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-1.94\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.052\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.78\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-2.18\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.029\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.53\u0026thinsp;\u0026plusmn;\u0026thinsp;0.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.67\u0026thinsp;\u0026plusmn;\u0026thinsp;0.98\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.64\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.50\u0026thinsp;\u0026plusmn;\u0026thinsp;0.67\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMonthly income\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026lt;\u0026thinsp;2\u0026nbsp;million won \u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.58\u0026thinsp;\u0026plusmn;\u0026thinsp;0.59\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e10.36\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.006\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.63\u0026thinsp;\u0026plusmn;\u0026thinsp;0.91\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e2.59\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.273\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.55\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e8.34\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.015\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.43\u0026thinsp;\u0026plusmn;\u0026thinsp;0.58\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e4.94\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.085\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2\u0026ndash;4\u0026nbsp;million won \u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.55\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003ea\u0026thinsp;\u0026gt;\u0026thinsp;c\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.73\u0026thinsp;\u0026plusmn;\u0026thinsp;1.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.79\u0026thinsp;\u0026plusmn;\u0026thinsp;0.48\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003ea\u0026thinsp;\u0026lt;\u0026thinsp;c\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.66\u0026thinsp;\u0026plusmn;\u0026thinsp;0.78\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4\u0026thinsp;\u0026gt;\u0026thinsp;million won \u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.20\u0026thinsp;\u0026plusmn;\u0026thinsp;0.25\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.35\u0026thinsp;\u0026plusmn;\u0026thinsp;0.88\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.83\u0026thinsp;\u0026plusmn;\u0026thinsp;0.47\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.72\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCancer stage\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e1 \u003csup\u003ea\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.15\u0026thinsp;\u0026plusmn;\u0026thinsp;0.23\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e7.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.056\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.20\u0026thinsp;\u0026plusmn;\u0026thinsp;0.69\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e2.20\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.531\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.77\u0026thinsp;\u0026plusmn;\u0026thinsp;0.69\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e2.48\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.478\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.74\u0026thinsp;\u0026plusmn;\u0026thinsp;0.73\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e3.10\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.372\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e2 \u003csup\u003eb\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.46\u0026thinsp;\u0026plusmn;\u0026thinsp;0.49\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.80\u0026thinsp;\u0026plusmn;\u0026thinsp;1.06\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.78\u0026thinsp;\u0026plusmn;\u0026thinsp;0.47\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.65\u0026thinsp;\u0026plusmn;\u0026thinsp;0.65\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e3 \u003csup\u003ec\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.40\u0026thinsp;\u0026plusmn;\u0026thinsp;0.50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.57\u0026thinsp;\u0026plusmn;\u0026thinsp;0.87\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.71\u0026thinsp;\u0026plusmn;\u0026thinsp;0.51\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.62\u0026thinsp;\u0026plusmn;\u0026thinsp;0.66\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e4 \u003csup\u003ed\u003c/sup\u003e\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.63\u0026thinsp;\u0026plusmn;\u0026thinsp;0.63\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.99\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.58\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.39\u0026thinsp;\u0026plusmn;\u0026thinsp;0.61\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eMetastasis\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.51\u0026thinsp;\u0026plusmn;\u0026thinsp;0.57\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-1.61\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.107\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.74\u0026thinsp;\u0026plusmn;\u0026thinsp;1.00\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-1.98\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.048\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.66\u0026thinsp;\u0026plusmn;\u0026thinsp;0.49\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-1.01\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.314\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.64\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-1.74\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.083\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.38\u0026thinsp;\u0026plusmn;\u0026thinsp;0.46\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.37\u0026thinsp;\u0026plusmn;\u0026thinsp;0.77\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.74\u0026thinsp;\u0026plusmn;\u0026thinsp;0.56\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.71\u0026thinsp;\u0026plusmn;\u0026thinsp;0.65\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eRadiation therapy\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eYes\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.54\u0026thinsp;\u0026plusmn;\u0026thinsp;0.58\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-0.88\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.380\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.56\u0026thinsp;\u0026plusmn;\u0026thinsp;0.90\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-0.21\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.838\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.72\u0026thinsp;\u0026plusmn;\u0026thinsp;0.51\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-0.17\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.868\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.49\u0026thinsp;\u0026plusmn;\u0026thinsp;0.53\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-0.64\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.520\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eNo\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.44\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.62\u0026thinsp;\u0026plusmn;\u0026thinsp;0.95\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.68\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.69\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eAnticancer drugs\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCytotoxic agent\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.48\u0026thinsp;\u0026plusmn;\u0026thinsp;0.54\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-1.06\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e.290\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.70\u0026thinsp;\u0026plusmn;\u0026thinsp;0.95\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u003cp\u003e-1.97\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u003cp\u003e.049\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.71\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u003cp\u003e-0.58\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u003cp\u003e.560\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.56\u0026thinsp;\u0026plusmn;\u0026thinsp;0.65\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u003cp\u003e-0.26\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u003cp\u003e.792\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003eOthers\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e1.40\u0026thinsp;\u0026plusmn;\u0026thinsp;0.52\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c6\"\u003e\u003cp\u003e1.32\u0026thinsp;\u0026plusmn;\u0026thinsp;0.83\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e\u003cp\u003e2.64\u0026thinsp;\u0026plusmn;\u0026thinsp;0.50\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c10\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c11\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c12\"\u003e\u003cp\u003e2.60\u0026thinsp;\u0026plusmn;\u0026thinsp;0.66\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c13\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c14\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colspan=\"1\" nameend=\"c15\" namest=\"c15\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colspan=\"15\" nameend=\"c15\" namest=\"c1\"\u003e\u003cp\u003ez-score calculated using the Mann\u0026ndash;Whitney U test; \u003cb\u003ex\u003c/b\u003e\u003csup\u003e\u003cb\u003e2\u003c/b\u003e\u003c/sup\u003e calculated using the Kruskal\u0026ndash;Wallis test; letters (a, b, c, d) presented for Bonferroni multiple comparison; M, mean; SD, standard deviation\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec16\" class=\"Section2\"\u003e\u003ch2\u003e3.3. Relationship between Cognition, Fatigue, HPBs, and QoL\u003c/h2\u003e\u003cp\u003eThe findings, based on Spearman's correlation analysis, indicated a correlation between fatigue (r\u0026thinsp;=\u0026thinsp;0.39, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001), HPBs (r = -0.43, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001), and QoL (r = -0.46, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001). Conversely, fatigue was negatively correlated with HPBs (r = -0.31, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;.001) and QoL (r = -0.57, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001). In contrast, HPBs positively correlated with QoL (r\u0026thinsp;=\u0026thinsp;0.71, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001) (Table\u0026nbsp;\u003cspan refid=\"Tab4\" class=\"InternalRef\"\u003e4\u003c/span\u003e).\u003c/p\u003e\u003cp\u003e\u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e\u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e\u003cdiv class=\"CaptionContent\"\u003e\u003cp\u003eRelationships among cognition, fatigue, health promotion behavior, and quality of life (\u003cem\u003eN\u003c/em\u003e\u0026thinsp;=\u0026thinsp;127)\u003c/p\u003e\u003c/div\u003e\u003c/caption\u003e\u003ccolgroup cols=\"5\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e\u003cp\u003eVariables\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003eCognition\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003eFatigue\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u003cp\u003eHealth promotion behavior\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u003cp\u003eQuality of life\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c2\"\u003e\u003cp\u003er (\u003cem\u003ep\u003c/em\u003e)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e\u003cp\u003er (\u003cem\u003ep\u003c/em\u003e)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e\u003cp\u003er (\u003cem\u003ep\u003c/em\u003e)\u003c/p\u003e\u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e\u003cp\u003er (\u003cem\u003ep\u003c/em\u003e)\u003c/p\u003e\u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eCognition\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eFatigue\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e.39 (\u0026lt;\u0026thinsp;.001)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eHealth promotion behavior\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026minus;\u0026thinsp;.43 (\u0026lt;\u0026thinsp;.001)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026minus;\u0026thinsp;.31 (\u0026lt;\u0026thinsp;.001)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e-\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e\u003cp\u003eQuality of life\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c2\"\u003e\u003cp\u003e\u0026minus;\u0026thinsp;.46 (\u0026lt;\u0026thinsp;.001)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c3\"\u003e\u003cp\u003e\u0026minus;\u0026thinsp;.57 (\u0026lt;\u0026thinsp;.001)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e\u003cp\u003e.71 (\u0026lt;\u0026thinsp;.001)\u003c/p\u003e\u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e\u003cp\u003e-\u003c/p\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/colgroup\u003e\u003ctfoot\u003e\u003ctr\u003e\u003ctd colspan=\"5\"\u003er by Spearman\u0026rsquo;s correlation analysis\u003c/td\u003e\u003c/tr\u003e\u003c/tfoot\u003e\u003c/table\u003e\u003c/div\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv id=\"Sec17\" class=\"Section2\"\u003e\u003ch2\u003e3.4. Mediating Effects of Fatigue and HPBs on the Relationship between Cognition and QoL\u003c/h2\u003e\u003cp\u003eMediation analysis using Hayes\u0026rsquo; PROCESS Macro indicated significant mediating roles of fatigue and HPBs in the relationship between cognition and QoL. The regression model satisfied the assumptions of normality, independence, and homoscedasticity with no evidence of multicollinearity. Cognition was positively associated with fatigue (B\u0026thinsp;=\u0026thinsp;0.16, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.003), which negatively affected QoL (B = -0.55, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001). Cognition also significantly influenced HPBs (B = -0.37, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001), which positively affected QoL (B\u0026thinsp;=\u0026thinsp;0.46, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001). Bootstrapping revealed significant indirect effects through both fatigue (B = -0.09, 95% CI [-0.160, -0.031]) and HPBs (B = -0.17, 95% CI [-0.278, -0.094]). The final model explained 65% of the variance in QoL (Table\u0026nbsp;5; Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e).\u003c/p\u003e\u003cp\u003e\u003c/p\u003e\u003cp\u003eTable\u0026nbsp;5. The mediating effects of fatigue and health promotion behavior in the relationship between cognition and quality of life (\u003cem\u003eN\u003c/em\u003e\u0026thinsp;=\u0026thinsp;127)\u003c/p\u003e\u003c/div\u003e\n\u003ctable border=\"1\" cellspacing=\"0\" cellpadding=\"0\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eDependent variable\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eIndependent variable\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eEffect(B)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003ese\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u003cem\u003ep\u003c/em\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eR\u003csup\u003e2\u0026nbsp;\u003c/sup\u003e\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eFatigue\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eCognition\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e0.16\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.05\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e.003\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e0.17\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eHealth promotion behavior\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eCognition\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e-0.37\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.08\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e0.23\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd rowspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003eQuality of Life\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eCognition\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e-0.13\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.06\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e.022\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e0.65\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003eFatigue\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e-0.55\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.09\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\u003cbr\u003e\u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003eHealth promotion behavior\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.46\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.06\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\u003cbr\u003e\u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eTotal effect\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e-0.39\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.07\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e\u0026lt;.001\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\u003cbr\u003e\u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eDirect effect\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e-0.13\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e0.06\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\n \u003cp\u003e.022\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd valign=\"top\"\u003e\u003cbr\u003e\u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eIndirect effect\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003eEffect(B)\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e\u003cstrong\u003e\u0026nbsp; \u0026nbsp; \u0026nbsp;Boot se [95% CI ]\u003c/strong\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;Cognition\u0026rarr;Fatigue\u0026rarr;Quality of Life\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e-0.09\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e0.03 [-0.160\u0026nbsp;-0.031]\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd colspan=\"4\" valign=\"top\"\u003e\n \u003cp\u003e\u0026nbsp;Cognition\u0026rarr;Health promotion behavior\u0026rarr;Quality of Life\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"2\" valign=\"top\"\u003e\n \u003cp\u003e-0.17\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd colspan=\"3\" valign=\"top\"\u003e\n \u003cp\u003e0.05 [-0.278, -0.094]\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp\u003eAbbreviations: se= standard error; LL= low level, UL=upper level; CI= confidence interval, Adjusted by covariates: Sex (Men=1); Religion, dummy variable (Yes=1), Job, dummy variable (Yes=1); Metastasis, dummy variable (Yes=1); Chemotherapy type, dummy variable (cytotoxic agent=1); Bootstrapping regression model for the parameters (number 4) with 50,000 bootstraps of the Process Macro\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e"},{"header":"4. Discussion","content":"\u003cp\u003eThis study examined the levels of cognitive function, fatigue, HPBs, and QoL in patients with GI cancer receiving chemotherapy and verified the mediating effects of fatigue and HPBs on the relationship between cognitive function and QoL.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn this study, the mean QoL score was 2.57 ± 0.65, consistent with the findings of previous studies using the same instrument [4]. Among the subdomains, the social/family domain scored the lowest (2.30 ± 0.92), consistent with our finding that patients with employment and those satisfied with family support reported higher QoL [4, 32]. Family and social support are associated with successful treatment, enhanced self-efficacy, and improved QoL [33], and can mitigate uncertainty and loneliness, positively influencing patients’ QoL [32]. Therefore, efforts to strengthen the social support systems for patients with GI cancer are essential.\u003c/p\u003e\n\u003cp\u003eCognitive function was identified as a major determinant of QoL, with 42.5% of participants classified as having mild amnestic cognitive impairment. The mean score for cognitive function was 1.46 ± 0.53, with memory (1.50 ± 0.55) being particularly impaired. This finding is consistent with those of prior studies reporting that approximately 38.8% of patients with GI cancer undergoing chemotherapy experience a decline in attention, memory, and executive functions [34]. Similarly, Oh and Kim [10,34] found that patients often experience forgetfulness, reduced work performance, and difficulties in daily activities, leading to frustration or job loss. In this study, cognitive decline was more pronounced among unemployed participants and those with lower incomes. Previous research has also shown that cognitive function is influenced by age, education, religious affiliation, occupation, income, family support, number of chemotherapy cycles, treatment duration, and type of chemotherapy [4, 6]. Moreover, the degree of impairment observed in this study was comparable to that typically seen in older adults, for whom cognitive decline is related to hippocampal atrophy caused by physiological stress and is strongly influenced by socioeconomic factors, such as education, income, and occupation [35]. These findings highlight the importance of routine cognitive assessments and supportive interventions for patients with cancer.\u003c/p\u003e\n\u003cp\u003eHPBs play a significant role in the relationship between cognitive function and QoL. The mean score was 2.69 ± 0.52, with the highest subdomain being nutrition management (2.92 ± 0.55). In contrast, physical activity (2.40 ± 0.85), health responsibility (2.46 ± 0.66), and stress management (2.38 ± 0.69) were relatively low. These results are consistent with those of previous studies, which have shown that patients with GI cancer prioritize nutrition but score lower on physical activity and stress management [16, 21].\u0026nbsp;Furthermore, HPBs were significantly higher among participants with religious affiliation, marital status, greater family support, and higher income, consistent with previous findings showing that social support and socioeconomic resources are key factors that influence health behaviors [25, 36]. Therefore, programs\u0026nbsp;targeting improvements in physical activity, health responsibility, and stress management, along with strengthening social support, are needed to enhance HPBs in patients with cancer.\u003c/p\u003e\n\u003cp\u003eFatigue is a key mediator of the relationship between cognitive function and QoL. The mean fatigue score was 1.60 ± 0.94, consistent with prior findings in patients with GI cancer [4, 25].\u0026nbsp;Fatigue significantly differed according to metastatic status and the use of cytotoxic agents, underscoring the importance of treatment-related factors in assessing fatigue. In this study, higher perceived cognitive impairment was associated with greater fatigue, lower HPBs, and, subsequently, lower QoL. This is consistent with previous findings showing that high fatigue levels reduce engagement in health behaviors, such as physical activity, adequate nutrition, stress management, and adherence to prescribed treatments [15, 22]. Conversely, interventions targeting fatigue reduction have been shown to improve physical activity, interpersonal relationships, and health behaviors, ultimately improving QoL [12, 37].\u0026nbsp;Similarly, improved HPBs are linked to reduced physiological stress responses and decreased fatigue [38]. Similar mechanisms have been proposed in other populations, such as patients with HIV, where lower memory scores are associated with higher treatment fatigue and poorer health-related QoL [39]. In addition, HPBs mediate the relationship between eHealth literacy and QoL in older adults [40].\u003c/p\u003e\n\u003cp\u003eTaken together, these findings suggest that cognitive decline in patients with cancer undergoing chemotherapy not only directly reduces their QoL, but also indirectly impairs it through increased fatigue and reduced HPBs. This highlights the need for integrated interventions that address cognitive function, fatigue management, and HPBs to improve the QoL of patients with GI cancer.\u003c/p\u003e"},{"header":"5. Limitations","content":"\u003cp\u003eThis study had some limitations. First, the cross-sectional design limited the ability to establish causal relationships among the variables. Longitudinal studies remain warranted to further examine the dynamic relationships among cognition, fatigue, HPBs, and QoL. Second, the use of convenience sampling may restrict the generalizability of the findings. Future studies using random sampling methods are recommended to enhance representativeness. Third, the participants were recruited from a specific region, which might have limited the external validity of the results. Broader sampling across diverse healthcare settings is required to strengthen the applicability of these results.\u003c/p\u003e"},{"header":"6. Conclusion","content":"\u003cp\u003eThis study demonstrated that cognitive decline among patients with GI cancer adversely affects their QoL through increased fatigue and reduced HPBs. These findings emphasize that cognitive impairment and fatigue are important treatment-related toxicities that require proactive supportive care. By identifying the mediating role of HPBs, this study provides an empirical basis for developing supportive interventions aimed at reducing fatigue, promoting self-management behaviors, and improving the QoL in this patient population.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003ch2\u003eCompeting Interests\u003c/h2\u003e\u003cp\u003eThe authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.\u003c/p\u003e\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eEthics Approval\u003c/strong\u003e\u003cp\u003e This study was conducted in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of Bundang CHA Medical Center (Approval No. CHAMC IRB 2024-07-025-003).\u003c/p\u003e\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eConsent to Participate\u003c/strong\u003e\u003cp\u003e Written informed consent was obtained from all individual participants included in the study.\u003c/p\u003e\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eConsent to Publish\u003c/strong\u003e\u003cp\u003eNot applicable.\u003c/p\u003e\u003c/p\u003e\u003ch2\u003eFunding\u003c/h2\u003e\u003cp\u003eThis research did not receive any financial support from funding agencies in the public, commercial, or not-for-profit sectors.\u003c/p\u003e\u003ch2\u003eAuthor Contribution\u003c/h2\u003e\u003cp\u003eB.L. wrote the original draft and performed methodology, investigation, software application, formal analysis, and data curation. S.K. supervised the study, contributed to data analysis, provision of resources and materials, and writing \u0026ndash; review and editing.All authors reviewed and approved the final manuscript. H.-J.P. supervised the study, contributed to methodology, performed formal analysis, conceptualization, and data interpretation, and contributed to writing \u0026ndash; review and editing.\u003c/p\u003e\u003ch2\u003eAcknowledgement\u003c/h2\u003e\u003cp\u003eThe authors would like to thank all participants for their time and commitment to this study.\u003c/p\u003e\u003ch2\u003eAvailability of Data and Materials\u003c/h2\u003e\u003cp\u003eThe datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eNational Cancer Information Center (2023) Cancer information service. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.cancer.go.kr/lay1/S1T289C290/contents.do\u003c/span\u003e\u003cspan address=\"https://www.cancer.go.kr/lay1/S1T289C290/contents.do\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eNational Cancer Center (2021) National Cancer Control Institute. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.cancer.go.kr/lay1/S1T648C650/contents.do\u003c/span\u003e\u003cspan address=\"https://www.cancer.go.kr/lay1/S1T648C650/contents.do\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eFillon M (2024) Osimertinib prolongs progression-free lung cancer survival after chemotherapy. CA Cancer J Clin 74(5):402\u0026ndash;404. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3322/caac.21862\u003c/span\u003e\u003cspan address=\"10.3322/caac.21862\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKim SA, Han SH (2021) Impacts of fatigue, anxiety, depression, and cognitive function on the quality of life in gastrointestinal cancer patients receiving chemotherapy. East West Nurs Res 27(2):185\u0026ndash;194. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.14370/JEWNR.2021.27.2.185\u003c/span\u003e\u003cspan address=\"10.14370/JEWNR.2021.27.2.185\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBrianna, Lee SH (2023) Chemotherapy: how to reduce its adverse effects while maintaining the potency? Med Oncol 40(3):88. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s12032-023-01954-6\u003c/span\u003e\u003cspan address=\"10.1007/s12032-023-01954-6\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOh PJ, Lee JR (2016) Effect of cancer symptoms and fatigue on chemotherapy-related cognitive impairment and depression in people with gastrointestinal cancer. J Korean Acad Nurs 46(3):420\u0026ndash;430. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.4040/jkan.2016.46.3.420\u003c/span\u003e\u003cspan address=\"10.4040/jkan.2016.46.3.420\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOh PJ, Lee JR (2016) Effect of cancer symptoms and fatigue on chemotherapy-related cognitive impairment and depression in people with gastrointestinal cancer. J Korean Acad Nurs 46(3):420\u0026ndash;430. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.4040/jkan.2016.46.3.420\u003c/span\u003e\u003cspan address=\"10.4040/jkan.2016.46.3.420\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWhittaker AL, George RP, O\u0026rsquo;Malley L (2022) Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis. Sci Rep 12:2135. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1038/s41598-022-05682-1\u003c/span\u003e\u003cspan address=\"10.1038/s41598-022-05682-1\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSchmidt JE, Beckjord E, Bovbjerg DH, Low CA, Posluszny DM, Lowery AE, et al (2016) Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. J Cancer Surviv 10(2):302\u0026ndash;311. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s11764-015-0476-5\u003c/span\u003e\u003cspan address=\"10.1007/s11764-015-0476-5\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKrynetskiy E, Krynetskaia N, Rihawi D, Wieczerzak K, Ciummo V, Walker E (2013) Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment. Life Sci 93(17):605\u0026ndash;610. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.lfs.2013.03.013\u003c/span\u003e\u003cspan address=\"10.1016/j.lfs.2013.03.013\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOh PJ, Kim JH (2022) The experience of chemotherapy-related cognitive impairment in patients with cancer. Asian Oncol Nurs 22(1):1\u0026ndash;10. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.5388/aon.2022.22.1.1\u003c/span\u003e\u003cspan address=\"10.5388/aon.2022.22.1.1\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOppegaard KR, Mayo SJ, Armstrong TS, Anguera JA, Kober KM, Miaskowski C (2023) The multifactorial model of cancer-related cognitive impairment. Oncol Nurs Forum 50(2):135\u0026ndash;147. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1188/23.ONF.135-147\u003c/span\u003e\u003cspan address=\"10.1188/23.ONF.135-147\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMuthanna FMS, Hassan BAR, Karuppannan M, Ibrahim HK, Mohammed AH, Abdulrahman E (2023) Prevalence and impact of fatigue on quality of life of cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Asian Pac J Cancer Prev 24(3):769\u0026ndash;781. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.31557/APJCP.2023.24.3.769\u003c/span\u003e\u003cspan address=\"10.31557/APJCP.2023.24.3.769\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eNCCN (2018) NCCN Guidelines Version 1.2018 Cancer-related fatigue. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf\u003c/span\u003e\u003cspan address=\"https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eVardy J, Dhillon HM, Pond GR, Rourke SB, Xu W, Dodd A, et al (2014) Cognitive function and fatigue after diagnosis of colorectal cancer. Ann Oncol 25(12):2404\u0026ndash;2412. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1093/annonc/mdu448\u003c/span\u003e\u003cspan address=\"10.1093/annonc/mdu448\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSalmani S, Mousavi SH, Navardi S, Hosseinzadeh F, Pashaeypoor S (2022) The barriers and facilitators to health-promoting lifestyle behaviors among people with multiple sclerosis during the coronavirus disease 2019 pandemic: a content analysis study. BMC Neurol 22(1):490. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1186/s12883-022-03072-1\u003c/span\u003e\u003cspan address=\"10.1186/s12883-022-03072-1\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eYang EH, Kang JH (2024) Effects of family support and health promotion behaviors on quality of life of cancer patients after gastrectomy. Asian Oncol Nurs 24(4):196\u0026ndash;204. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.5388/aon.2024.24.4.196\u003c/span\u003e\u003cspan address=\"10.5388/aon.2024.24.4.196\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eStrebkova R (2020) Cancer-related fatigue in patients with oncological diseases: causes, prevalence, guidelines for assessment and management. Folia Med 62(4):679\u0026ndash;689. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3897/folmed.62.e50517\u003c/span\u003e\u003cspan address=\"10.3897/folmed.62.e50517\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eDun L, Xian-Yi W, Si-Ting H (2022) Effects of cognitive training and social support on cancer-related fatigue and quality of life in colorectal cancer survivors: a systematic review and meta-analysis. Integr Cancer Ther 21:15347354221081271. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1177/15347354221081271\u003c/span\u003e\u003cspan address=\"10.1177/15347354221081271\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003ePeixoto NMDSM, Peixoto TADSM, Pinto CAS, Santos CSVB (2021) Nursing intervention focusing on health promotion behaviors in adult cancer patients: a scoping review. Rev Esc Enferm USP 55:e03673. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1590/S1980-220X2019039403673\u003c/span\u003e\u003cspan address=\"10.1590/S1980-220X2019039403673\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLee ES, Park JS (2013) The comparison of health promotion behavior, post traumatic growth and quality of life according to stages of survivorship in patients with female genital neoplasm. J Korean Acad Adult Nurs 25(3):312\u0026ndash;321. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7475/KJAN.2013.25.3.312\u003c/span\u003e\u003cspan address=\"10.7475/KJAN.2013.25.3.312\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKim MA, Lee HJ (2021) Impact of posttraumatic growth and health promoting behavior on quality of life in patients with gastrointestinal cancer. J Korean Acad Fundam Nurs 28(1):32\u0026ndash;42. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7739/jkafn.2021.28.1.32\u003c/span\u003e\u003cspan address=\"10.7739/jkafn.2021.28.1.32\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eKelly DL, Yang GS, Starkweather AR, Siangphoe U, Alexander-Delpech P, Lyon DE (2020) Relationships among fatigue, anxiety, depression, and pain and health-promoting lifestyle behaviors in women with early-stage breast cancer. Cancer Nurs 43(2):134\u0026ndash;146. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1097/NCC.0000000000000677\u003c/span\u003e\u003cspan address=\"10.1097/NCC.0000000000000677\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eHsia HH, Tien Y, Lin YC, Huang HP (2024) Factors influencing health promotion lifestyle in female breast cancer survivors: the role of health behavior self-efficacy and associated factors. Semin Oncol Nurs 40(2):151622. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.soncn.2024.151622\u003c/span\u003e\u003cspan address=\"10.1016/j.soncn.2024.151622\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eMols F, Schoormans D, de Hingh I, Oerlemans S, Husson O (2018) Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: prevalence, predictors, and impact on quality of life. Cancer 124(12):2621\u0026ndash;2628. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1002/cncr.31369\u003c/span\u003e\u003cspan address=\"10.1002/cncr.31369\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLee JR, Oh PJ (2016) Cognitive Decline and Quality of Life among Patients with Breast Cancer undergoing Chemotherapy: The Mediating Effect of Health Promotion Behavior. J Korean Acad Adult Nurs 28(2):202\u0026ndash;212. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7469/kjan.2016.28.2.202\u003c/span\u003e\u003cspan address=\"10.7469/kjan.2016.28.2.202\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eFarias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al (2008) The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology 22(4):531\u0026ndash;544. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1037/0894-4105.22.4.531\u003c/span\u003e\u003cspan address=\"10.1037/0894-4105.22.4.531\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eChung BY, Cho EJ (2012) Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncol Nurs 12(3):221\u0026ndash;229. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.5388/aon.2012.12.3.221\u003c/span\u003e\u003cspan address=\"10.5388/aon.2012.12.3.221\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32:811\u0026ndash;819\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOh PJ (1996) A structural model for health promotion and quality of life in people with cancer. J Nurses Acad Soc 26(3):632\u0026ndash;652\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eWalker SN, Sechrist KR, Pender NJ (1987) The Health-Promoting Lifestyle Profile: development and psychometric characteristics. Nurs Res 36(2):76\u0026ndash;81\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eCella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570\u0026ndash;579. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1200/JCO.1993.11.3.570\u003c/span\u003e\u003cspan address=\"10.1200/JCO.1993.11.3.570\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eZheng DN, Zheng XY, Luo QB, Cheng L, Cheng HD (2024) Study of the correlations between loneliness, disease uncertainty, and perceived social support among elderly patients with digestive tract tumors during treatment. Am J Transl Res 16(11):6758\u0026ndash;6769\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSawma T, Choueiri P (2022) The influence of family functioning on the severity of fear of cancer recurrence: a cross-sectional study in a sample of Lebanese breast cancer survivors. Eur J Oncol Nurs 60:102169. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1016/j.ejon.2022.102169\u003c/span\u003e\u003cspan address=\"10.1016/j.ejon.2022.102169\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eOh PJ, Moon SM (2019) Changes of cognitive function and fatigue following chemotherapy in patients with gastrointestinal cancer: a prospective controlled study. Asian Oncol Nurs 19(3):126\u0026ndash;134. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.5388/aon.2019.19.3.126\u003c/span\u003e\u003cspan address=\"10.5388/aon.2019.19.3.126\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eBurzynska AZ, Ganster DC, Fanning J, Salerno EA, Gothe NP, Voss MW, et al (2020) Occupational physical stress is negatively associated with hippocampal volume and memory in older adults. Front Hum Neurosci 14:266. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.3389/fnhum.2020.00266\u003c/span\u003e\u003cspan address=\"10.3389/fnhum.2020.00266\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eTabrizi FM (2015) Health promoting behavior and its influencing factors in Iranian breast cancer survivors. Asian Pac J Cancer Prev 16(5):1729\u0026ndash;1736. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.7314/APJCP.2015.16.5.1729\u003c/span\u003e\u003cspan address=\"10.7314/APJCP.2015.16.5.1729\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eSadeghi E, Gozali N, Moghaddam Tabrizi F (2016) Effects of energy conservation strategies on cancer-related fatigue and health promotion lifestyle in breast cancer survivors: a randomized control trial. Asian Pac J Cancer Prev 17:4783\u0026ndash;4790. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.22034/APJCP.2016.17.10.4783\u003c/span\u003e\u003cspan address=\"10.22034/APJCP.2016.17.10.4783\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLiang M, Liu Z, Zhang R, Zhang N (2025) Effect of exercise based on the ACSM recommendations on fatigue in patients with digestive tumors: a meta-analysis of randomized controlled trials. J Cancer Surviv 2025:1\u0026ndash;12. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s11764-025-01397-6\u003c/span\u003e\u003cspan address=\"10.1007/s11764-025-01397-6\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eAlcocer-Bruno C, Ferrer-Cascales R, Ruiz-Robledillo N, Clement-Carbonell V (2023) The mediation effect of treatment fatigue in the association between memory and health-related quality of life in men with HIV who have sex with men. Appl Neuropsychol Adult 2023:1\u0026ndash;11. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1080/23279095.2023.2298375\u003c/span\u003e\u003cspan address=\"10.1080/23279095.2023.2298375\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003cli\u003e\u003cspan\u003eLi S, Cui G, Yin Y, Wang S, Liu X, Chen L (2021) Health-promoting behaviors mediate the relationship between eHealth literacy and health-related quality of life among Chinese older adults: a cross-sectional study. Qual Life Res 30(8):2235\u0026ndash;2243. \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://doi.org/10.1007/s11136-021-02848-0\u003c/span\u003e\u003cspan address=\"10.1007/s11136-021-02848-0\" targettype=\"DOI\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"cognition, fatigue, health promotion, quality of life","lastPublishedDoi":"10.21203/rs.3.rs-7454615/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7454615/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003ch2\u003ePurpose\u003c/h2\u003e\u003cp\u003eCognitive disability, a common symptom among patients with gastrointestinal cancer undergoing chemotherapy, is frequently accompanied by fatigue and poor health promotion behaviors. These symptoms impair quality of life; however, their interrelationships remain unclear. This study aimed to determine whether fatigue and health promotion behaviors mediate the relationship between cognition and quality of life in patients with gastrointestinal cancer undergoing chemotherapy.\u003c/p\u003e\u003ch2\u003eMethods\u003c/h2\u003e\u003cp\u003eIn this cross-sectional study, 127 patients were recruited from a university hospital in South Korea. A quantitative mediation analysis was conducted. The participants completed validated self-report measures assessing cognition, fatigue, behaviors, and quality of life. Data were analyzed using Hayes\u0026rsquo; Process Macro with 50,000 bootstrap replicates.\u003c/p\u003e\u003ch2\u003eResults\u003c/h2\u003e\u003cp\u003eOur findings revealed that cognition influenced fatigue (B\u0026thinsp;=\u0026thinsp;0.47, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;=\u0026thinsp;0.003), health promotion behaviors (B\u0026thinsp;=\u0026thinsp;\u0026minus;\u0026thinsp;.35, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001), and quality of life (B = -0.51, \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001), and fatigue and health-promoting behaviors mediated the relationship between cognition and quality of life (B\u0026thinsp;=\u0026thinsp;\u0026minus;\u0026thinsp;.26, (95% CI, -0.345, -0.171), \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001; B\u0026thinsp;=\u0026thinsp;0.61, (95%CI, 0.453, 0.779), \u003cem\u003ep\u003c/em\u003e\u0026thinsp;\u0026lt;\u0026thinsp;0.001).\u003c/p\u003e\u003ch2\u003eConclusion\u003c/h2\u003e\u003cp\u003eCognition influences fatigue and health promotion behaviors, thereby directly impacting quality of life. Our findings support the need for integrated symptom management approaches in patient care. Interventions targeting fatigue and health promotion behaviors may be effective in reducing cognitive disability and improving the quality of life in patients with gastrointestinal cancer undergoing chemotherapy.\u003c/p\u003e","manuscriptTitle":"Mediating effects of fatigue and health promotion behaviors on cognition and quality of life among patients with gastrointestinal cancer undergoing chemotherapy: a cross-sectional study","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-10-20 13:47:41","doi":"10.21203/rs.3.rs-7454615/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"43d0c42b-2ab9-4e8f-9da3-4ebf99bd9e08","owner":[],"postedDate":"October 20th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2026-01-30T15:40:05+00:00","versionOfRecord":[],"versionCreatedAt":"2025-10-20 13:47:41","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7454615","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7454615","identity":"rs-7454615","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.